Are Patients’ Preferences for Osteoporosis Drug Treatment Transferable Between Countries? Results from a Discrete-Choice Experiment Conducted in Two European Countries (Englisch)
- Neue Suche nach: Hiligsmann, M.
- Neue Suche nach: Dellaert, B.
- Neue Suche nach: Dirksen, C.
- Neue Suche nach: Van der Weijden, T.
- Neue Suche nach: Goemaere, S.
- Neue Suche nach: McGowan, B.
- Neue Suche nach: Reginster, J. Y.
- Neue Suche nach: Watson, V.
- Neue Suche nach: Boonen, A.
- Neue Suche nach: Hiligsmann, M.
- Neue Suche nach: Dellaert, B.
- Neue Suche nach: Dirksen, C.
- Neue Suche nach: Van der Weijden, T.
- Neue Suche nach: Goemaere, S.
- Neue Suche nach: McGowan, B.
- Neue Suche nach: Reginster, J. Y.
- Neue Suche nach: Watson, V.
- Neue Suche nach: Boonen, A.
In:
VALUE IN HEALTH
;
16
, 7
;
A568-A569
;
2013
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Are Patients’ Preferences for Osteoporosis Drug Treatment Transferable Between Countries? Results from a Discrete-Choice Experiment Conducted in Two European Countries
-
Beteiligte:Hiligsmann, M. ( Autor:in ) / Dellaert, B. ( Autor:in ) / Dirksen, C. ( Autor:in ) / Van der Weijden, T. ( Autor:in ) / Goemaere, S. ( Autor:in ) / McGowan, B. ( Autor:in ) / Reginster, J. Y. ( Autor:in ) / Watson, V. ( Autor:in ) / Boonen, A. ( Autor:in )
-
Erschienen in:VALUE IN HEALTH ; 16, 7 ; A568-A569
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam
-
Erscheinungsdatum:01.01.2013
-
Format / Umfang:A568-A569
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 16, Ausgabe 7
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A323
-
Responsiveness of the EQ-5D in Oncology: A Meta-AnalysisSmith, A. B. / Cocks, K. / Taylor, M. / Parry, D. et al. | 2013
- A324
-
The Multimodel Ensemble Approach to Reducing Structural Uncertainty in Decision Analytical ModellingParham, P. E. / Hughes, D. A. et al. | 2013
- A325
-
Bayesian Calibration Method to Estimate Transition Probabilities for a Markov Model Based on a Continuous Outcome Measure: Application in Parkinson’s DiseaseNeine, M. / Briquet, B. / Mokdad, C. E. / Vataire, A. L. / Aballea, S. et al. | 2013
- A326
-
A Comparison of Methodologies for Estimating Survival in Patients Treated with Second-generation Tyrosine-kinase Inhibitors (TKIs) for Chronic Myeloid Leukaemia (CML)Pennington, B. / Batty, A. J. / Clifton-Brown, E. et al. | 2013
- A327
-
Application of Behavioural Economics to the Understanding of Adherence: Does an Individual’s Time Preference Influence Adherence to Medications?Fargher, E. A. / Morrison, V. / Plumpton, C. O. / Hughes, D. A. et al. | 2013
- A328
-
Quality Criteria for the Development of Implant RegistriesNiederländer, C. S. / Wahlster, P. / Kriza, C. / Schaller, S. U. / Kolominsky-Rabas, P. L. et al. | 2013
- A329
-
Mapping the CCQ onto EQ-5D Scores (Im)Possible?Boland, M. R. / van Boven, J. F. / Rutten-van Mölken, M. P. et al. | 2013
- A330
-
Uterine-sparing Surgical Treatment Modalities in Women with Uterine Fibroids: A Systematic Review and Indirect Treatment ComparisonPanagiotopoulou, N. / Nethra, S. / Karabis, A. / Ahmad, G. / Burls, A. et al. | 2013
- A331
-
Budget Impact of Dienogest in Treating Endometriosis Associated Pelvic Pain in Brazil: A Public Perspective AnalysisFerracini, M. / Nakada, C. P. et al. | 2013
- A332
-
A Cost of a Childbirth with in vitro Fertilization in PolandGóra, K. / Hermanowski, T. / Wrona, W. et al. | 2013
- A333
-
Systematic Literature Review and Cost-effectiveness Analysis of Fetal Fibronectin Test for Predicting Preterm in BrazilDecimoni, T. C. / Sansone, D. / Etto, H. / Santos, A. M. / Araújo, G. / Fonseca, E. S. / Fonseca, M. et al. | 2013
- A334
-
Cost Minimization Analysis of the Dienogest Use in Patients with Endometris under Brazilian Public and Private PerspectiveFerracini, M. / Nakada, C. P. et al. | 2013
- A335
-
A Systematic Review of Patient Preferences for Subcutaneous MedicationsRidyard, C. / Dawoud, D. / Hughes, D. A. et al. | 2013
- A336
-
Measurement of Societal Medical Care Preferences with the Same Cost Per Qaly: A Discrete Choice StudyShiroiwa, T. / Saito, S. / Shimozuma, K. / Kodama, S. / Noto, S. / Fukuda, T. et al. | 2013
- A338
-
Willingness to Pay (WTP) for a Brand Name Drug in Sâo Paulo, BrazilFerraz, M. B. / Nardi, E. P. et al. | 2013
- A339
-
Health Outcomes of Female Anabolic-Androgenic Steroid UsersNoone, J. / Blanchette, C. M. et al. | 2013
- A340
-
The Geographic Correlation Between Lyme Disease Incidence and Degenerative Neurological Disease Mortality: An Ecological StudyVeley, K. M. / Malka, E. S. et al. | 2013
- A341
-
Epidemiology, Treatment Outcomes and Costs of Treating Hepatitis C in Routine Care – Results from a Large Multicenter TrialStahmeyer, J. T. / Rossol, S. / Bert, F. / Abdelfattah, A. M. / Mauss, S. / Heyne, R. / John, C. / Pape, S. / Schober, A. / Teuber, G. et al. | 2013
- A342
-
Burden of Varicella in Eastern Europe: A Systematic Review and Critical AnalysisYang, H. K. / Song, K. M. / Manoff, S. / Liaw, K. L. / Kuter, B. et al. | 2013
- A343
-
Budget Impact of the Introduction of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir, the First Integrase Inhibitor-Based Single Tablet Antiretroviral Regimen for HIV Treatment, to Third Party Payers in the United StatesBrogan, A. / Talbird, S. E. / Thompson, J. R. / Kim, Y. A. / Olson, J. / Peterson, J. / Piontkowsky, D. / Pietrandoni, G. et al. | 2013
- A344
-
Examining the Relationship Between Country-Level Factors and Vaccine Wastage: A Data Driven Model of Session Sizes in Bangladesh, Mozambique, India (Uttar Pradesh), and UgandaYang, W. / Parisi, M. / Lahue, B. J. / Bishai, D. M. et al. | 2013
- A345
-
Pharmacoeconomic Evaluation of the Fixed-Dose Combination of Abacavir/Lamivudine in the Antiretroviral Therapy of Naïve HIV Infected Patients in RussiaPyadushkina, E. / Omelyanovsky, V. / Avxentyeva, M. / Rebrova, O. / Andreeva, N. et al. | 2013
- A346
-
Counting the Cost of Meningococcal Disease in FranceFaivre, P. / Bénard, S. / Wright, C. / Voisine, J. / Gaudelus, J. et al. | 2013
- A347
-
Evaluating Economic Burden of Tick-Borne Encephalitis. Evidence from RussiaAvxentev, N. / Avxentyeva, M. / Platonov, A. / Kolyasnikova, N. / Gridneva, K. / Dolgin, V. / Titkov, A. / Derkach, E. V. et al. | 2013
- A348
-
The Association Between Adherence to Antiretroviral Therapy and Economic Outcomes Among Commercially Insured and Medicaid HIV Patients in the United StatesKorsnes, J. S. / Goodwin, B. / Candrilli, S. D. et al. | 2013
- A349
-
Cost Associated with Adverse Events and Health Care Resources Utilization in Hepatitis C Virus Infection in Quebec, CanadaLachaine, J. / Vachon, M. L. / Lambert-Obry, V. / Beauchemin, C. et al. | 2013
- A350
-
When Treatment Is Mitigated by Adverse Events: The Economic Impact of Treatment-Associated Adverse Events in Cirrhotic Non-Responders Treated with Boceprevir or Telaprevir and Peginterferon Alpha/RibavirinSullivan, S. / McDermott, C. / Dieterich, D. / Martel-Laferriere, V. / Saab, S. / Gordon, S. et al. | 2013
- A351
-
Cost-Effectiveness Analysis of 3 Candins and Fluconazole in the Treatment of Confirmed Invasive Candidiasis in Adult Non-Neutropaenic Patients in SpainGrau, S. / Pozo, J. C. / Roma, E. / Salavert, M. / Collados, C. / Egea-GarcÃa, M. / Mesa, F. J. / Llevat, N. / Barrueta, A. et al. | 2013
- A352
-
Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in the Czech National Immunization ProgramTichopad, A. / Vitova, V. / Roberts, C. S. / Hájek, P. et al. | 2013
- A353
-
A Cost-Effectiveness Analysis of Linezolid Versus Vancomycin for Ventilator-Associated Pneumonia Patients in Costa RicaGarita, M. / Solano, A. / Cuesta, G. / Mould, J. et al. | 2013
- A355
-
Different Discounting Approaches and Their Impact in Economic Evaluation: A Practical Example Using Hepatitis B VaccinationCure, S. / Bianic, F. / Nandini Kahol, D. / Davie, A. et al. | 2013
- A356
-
Economic Analysis of Protease Inhibitors in First-Line Haart in Adult Patients with HIVAvxentyeva, M. / Goryaynov, S. / Rebrova, O. et al. | 2013
- A358
-
Cost-Minimization Analysis of Maraviroc Versus Darunavir Raltegravir and Enfuvirtide for CCR5-Tropic Treatment-Experienced Patients with HIV Infection in RussiaPyadushkina, E. / Omelyanovsky, V. / Avxentyeva, M. / Rebrova, O. / Goryaynov, S. et al. | 2013
- A359
-
COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLANDKaczor, M. P. / Wójcik, R. / Pawlik, D. / Skrzekowska-Baran, I. / Tronczynski, K. et al. | 2013
- A361
-
Patient Satisfaction with HIV Therapies: Focus on Adherence to TreatmentMurray, M. / Dang, N. / Swinburn, P. / Gallop, K. / Lloyd, A. et al. | 2013
- A362
-
Minimal Important Difference (MID) of Response to the Hepatitis-C Virus Patient Reported Outcomes (HCV-PRO) Instrument in a Trial of Pegylated Interferon/Ribavirin (pegIFN/RBV) and Direct-Acting-Antivirals (DAA)Baran, R. W. / Anderson, R. T. / Dietz, B. / Gooch, K. et al. | 2013
- A364
-
United States Policy Implications of Generic Substitution of Branded Human Immunodeficiency Virus MedicationsHogue, S. / Brogan, A. / Goodwin, B. et al. | 2013
- A365
-
Clinical Guidelines Evidence as a Criterion for Changes in the Legislation Combating TuberculosisStepanenko, A. / Lishchyshyna, O. / Melnyk, Y. et al. | 2013
- A366
-
RESPIRATORY Syncytial Virus Hospitalization in Infants with Congenital Airway Anomalies in the Canadian Registry of Synagis® (CARESS) Following Prophylaxis (2005-2012)Paes, B. A. / Li, A. / Mitchell, I. / Lanctot, K. L. et al. | 2013
- A367
-
Estimation of the Number of Cases of Nosocomial Pneumonia in Adults Caused by Gram-Positive Bacteria in Public Hospitals in MexicoGryzbowski, E. / Peniche-Otero, G. / Herrera-Rojas, J. / Bolaños-Cornejo, D. / Huicochea-Bartelt, J. L. / Muciño-Ortega, E. et al. | 2013
- A368
-
The Influence of Improved Adherence and Persistence in Chronic Obstructive Pulmonary Disease (COPD) Costs: Systematic Review of the LiteraturePérez, M. / Dominguez, J. / Armengol, S. / Paz, S. / Lizán, L. et al. | 2013
- A369
-
Impact of Chronic Pain on Health Care Costs in Chronic Obstructive Pulmonary Disease as Compared to Other Chronic DiseasesMapel, D. / Roberts, M. / Von Worley, A. et al. | 2013
- A370
-
Predicting Health Care Costs in Asthma Using the EQ-5D Index ScoreGu, N. Y. / Raisch, D. W. / Wu, J. / Gai, Y. / Hay, J. W. et al. | 2013
- A371
-
Cost-Effectiveness of Glycopyrronium Compared to Tiotropium in COPD Patients from a Swedish Societal PerspectiveCosta-Scharplatz, M. / Tambour, M. / Henriksson, F. / Ställberg, B. et al. | 2013
- A372
-
Empirical Therapy for Respiratory Tract Infections in an Era of Increasing Antimicrobial Resistance: A Decision and Cost AnalysisBabela, R. et al. | 2013
- A373
-
Factors Related to Adherence After a Multifactorial Intervention to Improve It in Patients with Chronic Obstructive Pulmonary Disease (COPD). Icepoc StudyLeiva-Fernandez, F. / Leiva-Fernandez, J. / Prados-Torres, D. / GarcÃa-Ruiz, A. J. / Barnestein-Fonseca, P. et al. | 2013
- A374
-
Patient-Reported Outcome (PRO) Claims in Products Approved for Chronic Obstructive Pulmonary Diseases (COPD) in Europe and the United StatesCaron, M. / Perrier, L. L. / Acquadro, C. et al. | 2013
- A375
-
The Rand Negative Impact of Asthma on Quality of Life Item Bank and Short-FormsSherbourne, C. / Stucky, B. / Edelen, M. O. / Eberhart, N. / Lara, M. et al. | 2013
- A376
-
Patterns in Asthma Medicationtreatment in the United StatesLi, Y. / Suh, K. / Chen, W. / Wei, Z. / Higuchi, K. et al. | 2013
- A377
-
Clinical Effectiveness Analysis of Deferasirox for the Treatment of Iron Overload Due to Frequent Blood TransfusionsWalczak, J. / Lipińska, M. / Jarosz, J. / Moczyński, W. / Ślązak, B. / Laczewski, T. et al. | 2013
- A378
-
Budget Impact Analysis of Deferasirox in the Treatment of Non Transfusion Dependent Thalassemia in GreeceMasoura, P. / Murphy, D. R. / Chatzikou, M. / Alexopoulos, S. T. / Magestro, M. et al. | 2013
- A379
-
Pharmacoeconomic Evaluation of Intravenous Ferric Carboxymaltose and Iron Sucrose in Correction of Preoperative Anaemia in Patients Undergoing Major Elective SurgeryGorokhova, S. G. / Ryazhenov, V. V. / Emchenko, I. V. et al. | 2013
- A380
-
Haemophilia A: Annual Cost Comparison Between FL-rFVIII and BDD-rFVIII in France: We Should Compare the Cost Per Patient Instead of the Price Per UnitHaarmann, H. / Epstein, J. / Grumel, O. et al. | 2013
- A381
-
A Systematic Literature Review on the Epidemiology and Economic Burden of Anaemia Associated with Chronic Kidney DiseaseRizzo, M. / Iheanacho, I. / van Nooten, F. E. / Goldsmith, D. et al. | 2013
- A382
-
Cost-Consequence Analysis of a Treatment Strategy Including Ponatinib Compared to a Treatment Strategy Including Only the 2nd Generation Tyrosine Kinase Inhibitors (2g TKIs), Dasatinib or Nilotinib, in Resistant Patients with Philadelphia Chromosome-Positive (Ph+) Leukemia, in ItalyChiroli, S. / Furneri, G. / Pane, F. et al. | 2013
- A383
-
The Potential of a Reduction in the Risk of Opioid-Related Fractures to Drive the Cost-Effectivness of an AnalgesicCawson, M. / Knight, C. / Hirst, M. / Dunlop, W. et al. | 2013
- A384
-
Cost-Effectiveness of Plerixafor (PXF) for Stem Cell Mobilization in Lymphoma (NHL/HL) and Multiple Myeloma (MM) Patients in PolandKaczor, M. P. / Wójcik, R. / Pawlik, D. / Glasek, M. / Pieczonka, A. / Lis, J. et al. | 2013
- A385
-
Full Cost of Plasma from Voluntary Non Remunerated Donors in ItalyZaniolo, O. / Povero, M. / Gandini, G. / Aprili, G. / Eandi, M. et al. | 2013
- A386
-
The Use of Preference Based Measures in Haemophilia: Is the Current Evidence Base Useful for Evidence Based Decision Making?Tolley, K. / Miners, A. / Brazier, J. / Pericleous, L. M. / Sharma, T. / Petersen, J. / Lonergan, T. et al. | 2013
- A387
-
The Impact of Increasing Pain Severity on Impairment of Regular Daily ActivitiesPoole, C. D. / Chambers, C. / Odeyemi, I. / Currie, C. et al. | 2013
- A388
-
Likelihood of Use and Perception Towards Biosimilars in Rheumatoid Arthritis Arena: Survey of Rheumatologists in European Union, Brazil, Japan and ChinaNarayanan, S. / Liu, L. et al. | 2013
- A389
-
Appetite Suppressants: A Drug Utilisation StudyTruter, I. et al. | 2013
- A390
-
Cost-Minimization of Mabthera Intravenous Versus Subcutaneous AdministrationBax, P. / Postma, M. J. et al. | 2013
- A392
-
Evaluation of the Burden of Illness of Colorectal Cancer Among Veteran Patients in the United StatesWang, L. / Xie, L. / Li, L. / Wang, Y. / Kariburyo, M. F. / Baser, O. et al. | 2013
- A393
-
An Indirect Treatment Comparison of the Efficacy of Everolimus (Afinitor®) and Fulvestrant for the Treatment of Hormone Receptor Positive (HR+) HER2 Negative (HER2–) Advanced or Metastatic Breast CancerChandiwana, D. / Vieira, J. / Granville, J. / McCool, R. / Fleetwood, K. et al. | 2013
- A394
-
A Mixed Treatment Comparison (MTC) to Compare Progression Free Survival (PFS) Associated with Different Chemotherapy Regimens for Platinum-Sensitive or Partially Platinum-Sensitive Recurrent Advanced Ovarian CancerEdwards, S. J. / Barton, S. / Thurgar, E. / Wakefield, V. / Karner, C. / Trevor, N. et al. | 2013
- A395
-
Second-Line Treatment of Metastatic Colorectal Cancer (mCRC): A Systematic Literature Review (SLR) and Feasibility Assessment of Conducting Indirect Treatment Comparison (ITC) AnalysisXu, Y. / Martin, A. L. / Ross, S. / Knopf, K. B. / Strand, L. / Iqbal, S. U. / Joulain, F. / Jasso Mosqueda, J. G. / Fahrbach, K. et al. | 2013
- A396
-
Off-Label Trastuzumab Usage in Breast Cancer Patient in TurkeyKockaya, G. / Tanyeri, P. / Buyukokuroglu, M. E. / Yenilmez, F. B. / Durmus, D. / Vural, I. M. / Akbulat, A. / Artiran, G. / Gursoz, H. / Kerman, S. et al. | 2013
- A397
-
Aflibercept + FOLFIRI (AF) Versus. Placebo + FOLFIRI (PF) in Metastatic Colorectal Cancer (mCRC): Mean Overall Survival (OS) in a “Better Responders†Patient Population of the Velour TrialJoulain, F. / Naoshy, S. / Chau, I. / Iqbal, S. U. / Bridgewater, J. et al. | 2013
- A398
-
Economic Impact of Denosumab for Skeletal Related Event Prevention in Patients with Prostate Cancer and Bone Metastasis from a United State Managed Care Organization PerspectiveArellano, J. / Cristino, J. / Chen, K. et al. | 2013
- A399
-
Breast Cancer Screening Program in the Basque Country: Costs and Health Benefits Assessment Through Discrete Event SimulationArrospide, A. / Mar, J. / Comas, M. / Rue, M. / Larrañaga, N. / Acaiturri, T. / Sarriugarte, G. et al. | 2013
- A400
-
Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic LeukemiaWalzer, S. / Tournier, C. / Marino, J. P. / Mueller, E. / Duong, M. et al. | 2013
- A401
-
Cost of Adverse Events During Treatment with Everolimus Plus Exemestane or Single-Agent Chemotherapy in Patients with Advanced Breast CancerCampone, M. / Yang, H. / Faust, E. / Kageleiry, A. / Signorovitch, J. / Zhang, J. / Gao, H. et al. | 2013
- A402
-
Costs of Pilot Programs Employing Allied Health Professionals Within the Centers for Population Health and Health DisparitiesWalton, S. / Johnson, T. J. / Li, C. C. / Joyce, B. et al. | 2013
- A403
-
The Humanistic and Economic Burden of Venous Thromboembolism in Cancer Patients: A Systematic ReviewKourlaba, G. / Relakis, J. / Kontodimas, S. / Holm, M. V. / Maniadakis, N. et al. | 2013
- A404
-
Estimating the Cost of HPV-Related Diseases in Turkey: A Delphi ApproachBakir, M. / Ayhan, A. / Arvas, M. / Kose, M. F. / Gungor, M. / Ortac, F. / Ozgul, N. / Yuce, K. / Ergun, T. / Gungor, E. et al. | 2013
- A405
-
Economic Burden of Toxicities Associated with Advanced Melanoma Treatments in France, Italy, the Netherlands, and SpainBilir, S. P. / Zhao, Z. / Wehler, E. A. / Munakata, J. / Barber, B. et al. | 2013
- A407
-
Estimation of the Epidemiological and Economic Impact of the Quadrivalent HPV Vaccination in Girls and Boys in SpainBosch, X. / Cortés Bordoy, J. / Gil de Miguel, A. / López Belmonte, J. L. / Bresse, X. / Serip, S. / Nieves, D. et al. | 2013
- A408
-
Cost-Effectiveness of the Optical Imaging Agent Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder CancerMarteau, F. / Kornowski, A. / Bennison, C. / Tempest, M. J. / Mariappan, P. / Witjes, J. A. et al. | 2013
- A409
-
Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germanyvan Beurden-Tan, C. / Rosiñol, L. / Diels, J. / Wirth, D. / Chirita, O. / Lahuerta, J. J. / Gaugris, S. / Marsh, S. / San Miguel, J. / Spencer, M. et al. | 2013
- A410
-
Overview on Cost-Effectiveness Results of Decision-Analytic Studies for the Treatment of Multiple MyelomaRochau, U. / Jahn, B. / Qerimi, V. / Kluibenschaedl, M. / Kurzthaler, C. / Conrads-Frank, A. / Willenbacher, W. / Gastl, G. / Siebert, U. et al. | 2013
- A411
-
A Cost-Effectiveness Analyses of Using Sunitinib (SU) in First Line of Metastatic Renal Cancer in Romanian JurisdictionBerghea, F. / Skoupa, J. / Ciuleanu, T. / Miron, L. / Stanculeanu, D. L. / Jinga, D. / Dediu, M. / Mateescu, D. N. / Hájek, P. / Bradatan, B. et al. | 2013
- A413
-
Pharmacoeconomic Analysis of Using Aprepitant Plus Standard Antiemetic Therapy for Prevention of Nausea and Vomiting Associated with Highly and Moderately Emetogenic Cancer Chemotherapy in RussiaKrysanov, I. / Krysanova, V. et al. | 2013
- A414
-
Cost-Effectiveness of First-Line Treatment of Advanced Metastatic Non Small Cell Lung Cancer- A Systematic Review of Economic ModelsEijgelshoven, I. / Verduyn, S. C. / Bhatti, T. / Bexelius, C. / Jansen, J. P. et al. | 2013
- A415
-
Cost-Effectiveness Analysis of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Treatment in JapanShibahara, H. / Shiroiwa, T. / Nakamura, K. / Shimozuma, K. et al. | 2013
- A416
-
Head to Head Economic Evaluation of Two Genomic Profiles of Recurrence Risk for Breast Cancer, Mammaprint Versus Oncotype DX, in SpainCrespo, C. / SeguÃ, M. / Cortés, J. / Lluch, A. / Brosa, M. / Becerra, V. / Chiavenna, S. M. / Gracia, A. et al. | 2013
- A417
-
Economic Activity of Cancer Survivors in PolandMacioch, T. / Hermanowski, T. R. et al. | 2013
- A418
-
Persistence in Patients with Breast Cancer Treated with Tamoxifen or Aromatase Inhibitors- Analysis Based on Oncology Analyzer DatabaseSchmidt, N. / Haas, G. / Mergenthaler, U. / Kostev, K. / Hadji, P. et al. | 2013
- A420
-
Systematic Review of Patient Reported Outcomes in Chronic Myeloid LeukemiaAggarwal, S. / Segal, J. / Topaloglu, H. et al. | 2013
- A421
-
Influence of Anxiety and Depression on 1-Year Health Related Quality of Life in Colorectal Cancer PatientsEscobar, A. / Billbao, A. / Trancho, Z. / Quintana, J. / Sarasqueta, C. / Baré, M. et al. | 2013
- A422
-
HR-QOL Data in the Amnog Early Benefit Assessment: Industry and IQWIG/GBA PerspectiveObradovic, M. / Radicek, S. / Rauland, M. et al. | 2013
- A424
-
Are ICER Threshold Values Malleable? The Case of Life-Extending Cancer Treatments at the End of LifeMoïse, P. / Sweeney, N. / Lie, X. et al. | 2013
- A425
-
A Disease Model of Metastatic Colorectal Cancer Including Multiple Treatment Linesvan Rooijen, E. M. / Uyl-de Groot, C. A. / Punt, C. / Koopman, M. / Coupe, V. M. et al. | 2013
- A427
-
A Novel Algorithm Using Claims Data to Identify Patients with Castration-Resistant Prostate Cancer (CRPC)Gorritz, M. / Thompson, S. F. / Lee, Y. C. / Stern, L. / Penson, D. F. et al. | 2013
- A428
-
Impact of Recommended Pharmaceuticals on Cancer Mortality: Analysis of Real-Life DataWilson, T. / Hamerslag, L. et al. | 2013
- A429
-
Economical Losses Due to Disablementparents Carring for Children with Oncohematological DiseasesGanieva, D. / Zhukovskaya, E. / Spichak, I. et al. | 2013
- A432
-
A Bayesian Multiple Treatment Comparison of Duloxetine, Pregabalin, Gabapentin, Amitriptyline, and Their Combinations for Painful Peripheral Neuropathy Based on Pain Reduction Reported in Clinical TrailsChinthammit, C. / Malone, D. et al. | 2013
- A433
-
The Presence of Metabolic and Other Risk Factors in Adrenal Insufficiency Patients Compared to an Unmatched Background Population from the Same Region in the United KingdomTeneishvili, M. / Marelli, C. / Lee, D. et al. | 2013
- A434
-
Early Life Determinants of Metabolic Syndrome and Diabetes Mellitus in South Asian Population Living in Europe: A Systematic ReviewCallejo, D. / DÃaz-Cuervo, H. / Cuervo, J. / Rebollo, P. / Hussain, A. / Hitman, G. A. et al. | 2013
- A436
-
Quantifying the Direct and Indirect Costs Associated with Severe and Non-Severe Hypoglycaemia in Subjects with Type-2 Diabetes Who Are Treated with InsulinFoos, V. / Grant, D. / Palmer, J. L. / Varol, N. / Curtis, B. / Boye, K. S. / McEwan, P. et al. | 2013
- A437
-
First Russian Type 2 Diabetes Mellitus Simulation Model with Discrete Events Modeling. Health-Economic AnalysisKolbin, A. / Kurylev, A. / Balykina, Y. / Proskurin, M. et al. | 2013
- A439
-
Health-Economic Comparison of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for the Treatment of Type 1 Diabetes in Kazakhstan ChildrenRoze, S. / Demessinov, A. / Zeityn, M. / Toktarova, N. / Abduakhassova, G. / Sissemaliev, R. / Karamalis, M. / Dunne, N. / Muratalina, A. / Klots, M. et al. | 2013
- A440
-
Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Sitagliptin (SITA) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK SettingWillis, M. / Johansen, P. / Schroeder, M. / Thompson, G. / Girod, I. / Neslusan, C. et al. | 2013
- A441
-
Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Glimepiride (GLIM) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK SettingGirod, I. / Willis, M. / Johansen, P. / Schroeder, M. / Thompson, G. / Neslusan, C. et al. | 2013
- A442
-
The Cost-Utility of Insulin Degludec Compared with Current Standard of Care in the Management of Type One and Type Two Diabetes Mellitus in BelgiumJugrin, A. V. / Lamotte, M. / Malfait, M. / Vandebrouck, T. et al. | 2013
- A443
-
Review of Cost of Diabetes Complications in Four European CountriesBeaudet, A. / Grabbi, E. / Maurel, F. / Ramos, M. / Lebioda, A. et al. | 2013
- A444
-
Do Fixed-Dose Combinations Improve Antidiabetic Treatment Compliance? A Study Based on French IMS Lifelink Disease Analyzer DatabaseGrandfils, N. / Le Jeunne, P. / Maillard, C. / Solomiac, A. / Besson, A. et al. | 2013
- A445
-
Health-Related Quality of Life and Utility in Patients with Diabetic Foot Syndrome - An EQ-5D Survey in PolandSobol, E. / Macioch, T. / Krakowiecki, A. / Mrozikiewicz-Rakowska, B. / Mienicka, A. / Mlynarczuk, M. / Kasprowicz, M. / Paweska, J. / Karnafel, W. / Hermanowski, T. R. et al. | 2013
- A446
-
Assessing Quality of Life in Adult Growth Hormone Deficiency: Further Development of the QoL-AGHDAGraham, J. E. / McKenna, S. / Wilburn, J. / Twiss, J. et al. | 2013
- A448
-
Impact of Nocturnal and Daytime Non-Severe Hypoglycaemic Events on People with Diabetes in South AfricaSnyman, J. / Todorova, L. et al. | 2013
- A449
-
The Impact of Memory Problems on Diabetes Treatment in GermanyBrod, M. / Kongso, J. / Bushnell, D. M. et al. | 2013
- A451
-
Real Life Applications of Social Security Institution (SSI) Regulations; A Case Study of DPP4 Inhibitors in Treatment of Diabetes in Turkish Health Care SystemKececioglu, S. / Ulus, P. / Cukadar, F. / Ozkan, M. / Urganci, B. et al. | 2013
- A453
-
How Co-Payment Mechanism Has Changed Patients’ Perception Towards Otc-Type Products?Deger, C. C. / Tuna, E. / Ozdemir, Z. / Ozel, M. O. / Parali, E. / Sumer, F. / Yilmaz, Z. S. et al. | 2013
- A455
-
Characterising Preliminary Profile Paramaters for FDA Breakthrough Therapy CandidatesLabban, M. / Izmirlieva, M. / Ando, G. et al. | 2013
- A456
-
2.5 YEARS OF AMNOG IN GERMANY – AN ANALYSIS OF BENEFIT ASSESSMENT AND NET PRICE NEGOTIATION TRENDSDehnen, J. / Schmoeller, M. et al. | 2013
- A457
-
Pricing of “Follow-On†Drugs and Competition Within Pharmaceutical Classes: Evidence from Germany 1993-2008Mueller, M. T. / Frenzel, A. et al. | 2013
- A458
-
Constructing an Index of International Pharmaceutical Prices. A Comparison of Pharmaceutical Prices in 56 CountriesDavey, P. et al. | 2013
- A459
-
EU Payer and Decision Maker Use of Observational Studies for Health Care Reimbursement DecisionsHogue, S. / Hollis, K. / McLeod, L. / Brogan, A. / Heyes, A. E. et al. | 2013
- A460
-
How Does Prescription of Generic Drugs Spread Out?: Data Mining and Visualization by Using Prescription Data Form Acute Care Hospitals NationwideShimizu, S. / Ishikawa, K. B. / Ikeda, S. / Fushimi, K. et al. | 2013
- A461
-
A Systematic Evaluation of Drug-Drug Interactions in Prescriptions; Facts and ComparisonsAhmad, M. / Arshad, W. / Usman Minhas, M. et al. | 2013
- A462
-
Current Status and Evidence of Effects of E-Prescribing Implementation in United Kingdom, Italy, Germany, Denmark, Poland and United StatesHermanowski, T. R. / Kowalczyk, M. / Szafraniec-Burylo, S. I. / Krancberg, A. N. / Pashos, C. L. et al. | 2013
- A463
-
Geographical Inequalities in the Access to and Utilization of Home Care (Nursing) Services in HungaryCs. Horváth, Z. / Molics, B. / �goston, I. / Sebestyén, A. / Boncz, I. et al. | 2013
- A464
-
Variability in Publically-Prescribed Drug Costs: The Role of Region, Age and GenderO Céilleachair, A. J. / Woods, N. / O’Sullivan, K. / Kenneally, M. et al. | 2013
- A465
-
Cost-Effectiveness of an Interface Geriatric Intervention: Acute Medical Unit Comprehensive Geriatric Assessment Intervention Study (AMIGOS)Tanajewski, L. / Franklin, M. / Gkountouras, G. / Berdunov, V. / Edmans, J. / Conroy, S. / Bradshaw, L. / Gladman, J. / Elliott, R. A. et al. | 2013
- A466
-
Pharmaceutical Expenditure, Clinical Outcomes and Expenditures on Other Health ServicesSiskou, O. / Galanis, P. / Tsavalias, K. / Kalogeropoulou, M. / Kaitelidou, D. / Pasaloglou, S. / Schneider, M. / Liaropoulos, L. et al. | 2013
- A468
-
Impact of Pharmacoeconomics Modelling on Reimbursement of Medicines in SerbiaMedic, G. / Baltezarevic, D. / Novakovic, T. et al. | 2013
- A469
-
Acceptability of Indirect Evidence to Support Drug Reimbursement in AustraliaO’Leary, B. A. / McKenna, S. J. / Cheng, Y. Y. / McElroy, H. J. et al. | 2013
- A471
-
Investigating Safety-Appraoch in Saudi Arabia Ministry of Health HospitalsAlkelya, M. A. / Haleem, R. M. et al. | 2013
- A472
-
Confidential Patient Access Schemes in the United Kingdom – Do They Affect Prices in Other Markets?Nijhuis, T. / Haigh, J. / Van Engen, A. et al. | 2013
- A473
-
A Systematic Comparison of Market Access and Reimbursement Pathways for Diagnostic Tests in Germany, United Kingdom and the United StatesWalzer, S. / Gartemann, J. et al. | 2013
- A474
-
Pricing and Reimbursment of Pharmaceuticals in IranMoradi, M. et al. | 2013
- A475
-
A Comparison of Coverage and Reimbursement Decisions in Germany (AMNOG) and Scotland (SMC)Charokopou, M. / Heeg, B. / Schoeman, O. / Mueller, S. / Tempest, M. J. / Schlagmüller, S. C. / Wilke, T. et al. | 2013
- A476
-
Point of Care Tests: The Long and Winding Road to ReimbursementHogue, S. / Brogan, A. / Heyes, A. et al. | 2013
- A478
-
Effects of Changing Health Policy on Pharmacoeconomics and Health Outcome Studies from 2000 to 2012 in TurkeyKockaya, G. / Daylan Kockaya, P. / Ergin, G. et al. | 2013
- A479
-
Workshop in Pharmacoeconomics: An Italian Experience of Multi-Stakeholder Hta ConsensusCicchetti, A. / Gasbarrini, A. / Ruggeri, M. / Sacchini, D. / Lanati, E. P. et al. | 2013
- A480
-
Key Drivers of Pbac Decisions for the Reimbursement of Orphan Drugs on the Life Saving Drugs ProgramMaguire, B. / Tilden, D. et al. | 2013
- A481
-
Analysis of Transparency Amongst International Health Technology Assessment OrganizationsJebrail, F. / Duong, M. / Shum, D. et al. | 2013
- A482
-
Which Should Be the Correct NMA to Be Used? A Review of HTA RecommendationsSolozabal, M. / Roset, M. / Rojas-Farreras, S. / González-Rojas, N. / Gil, A. et al. | 2013
- A483
-
Number of Submissions Needed to Reach a Positive Reimbursement Decision from SMC, CADTH, and PBACJaksa, A. / Ho, Y. S. / Daniel, K. et al. | 2013
- A484
-
Relevance of Indirect Comparisons in the German Early Benefit Assessment (AMNOG)Lebioda, A. / Gasche, D. / Dippel, F. W. / Plantör, S. et al. | 2013
- A485
-
Systematic Review on Use of Economic Evidence by Clinical GuidelinesAggarwal, S. / McGrane, M. / Topaloglu, H. et al. | 2013
- A486
-
Guidance for Partnership Working Between CatSalut and the Pharmaceutical IndustryGilabert, A. / Espinosa, C. / Mora, R. / Santos, J. et al. | 2013
- A487
-
Coverage with Evidence Development in Sweden – Formality or Effective Way to Reduce Uncertainty?Kornfeld, A. / Schroeder, M. / Toumi, M. et al. | 2013
- A489
-
The Framework for Health Economic Modeling and Multi-Criteria Decision Analysis (MCDA) on the Example of the Mobile Stroke Unit (MSU)Wahlster, P. / Niederländer, C. S. / Kriza, C. / Kolominsky-Rabas, P. L. et al. | 2013
- A490
-
How Do Oncology Drug Prices Vary Across EU5, the United States, and Bric Markets?Patel, P. / Donze, B. / Zaganelli, D. et al. | 2013
- A491
-
Review of Economic Principles of Branded “Me-Too†Drugs MarketHren, R. et al. | 2013
- A492
-
Understanding the Effect of Clostridium Difficile Infection on Hospital Mortality in England, the Netherlands, and SpainWasserman, M. / Jones, C. / Roberts, G. / Latif, F. et al. | 2013
- A494
-
Organizational and Economic Issues Related to the Introduction of Boceprevir in the Treatment of Patients with Genotype 1 Chronic Hepatitis C in ItalyLa Torre, G. / Miele, L. / Mannocci, A. / Saulle, R. / Giraldi, G. / Unim, B. / Ursillo, P. / Semyonov, L. / Colamesta, V. / Melcarne, R. et al. | 2013
- A495
-
Utilisation and Costs of Inpatient and Outpatient Services Among Patients with Irritable Bowel Syndrome- A Study Using the Clinical Practice Research Datalink (CPRD)Murray-Thomas, T. / Dedman, D. / Canavan, C. / West, J. / Card, T. et al. | 2013
- A496
-
An Economic Evaluation Comparing ePTFE Covered Stent-Grafts Configured for Tips with Bare Metal Stents in Procedures for the Treatment of Portal Hypertension ComplicationsBurke, M. / Hacking, N. / Wright, M. / Iqbal, K. / Craig, J. et al. | 2013
- A497
-
Crohn’s Disease: An Economic Assessment of Biological Drugs in ItalyCicchetti, A. / Gasbarrini, A. / Ruggeri, M. et al. | 2013
- A499
-
Validation of the Crohn’s Life Impact Questionnaire (CLIQ), the First Patient-Reported Outcome Measure Specific to Adults with Crohn’s DiseaseWilburn, J. / McKenna, S. / Twiss, J. / Kemp, K. / Campbell, S. et al. | 2013
- A500
-
Systematic Literature Review in Moderate to Severe Ulcerative ColitisHuisman, E. / Medic, G. / Eijgelshoven, I. / Weijers, L. / Karabis, A. et al. | 2013
- A501
-
Indirect Comparison of the Effect of Biologics in Patients with Psoriasis; A Meta-Analysis of Randomized, Double Blind Clinical Trials in Bayesian FrameworkBrodszky, V. / Mo, M. / Gulacsi, L. / Baji, P. / Balogh, O. / Péntek, M. et al. | 2013
- A502
-
Children with Atopic Dermatitis: Monitoring a French Cohort Over a Nine-Year PeriodTaieb, C. et al. | 2013
- A503
-
Spectacle Independence and Vision-Related Quality of Life in Cataract Surgery Patients Following Implantation of a Multifocal Intraocular LensSamiian, A. / Carones, F. et al. | 2013
- A504
-
Costs of Best Supportive Care in the Treatment of Moderate-To-Severe Psoriasis in the United StatesTencer, T. / Li, S. / Zhang, F. et al. | 2013
- A505
-
Cost-Effectiveness of Biologic Therapies for the Treatment of Moderate to Severe Psoriasis in the United KingdomBetts, K. A. / Sundaram, M. / Mughal, F. / Yan, S. Y. / Signorovitch, J. / Wang, K. / Wu, E. Q. et al. | 2013
- A506
-
The Cost-Effectiveness of Bimatoprost 0.03%/Timolol 0.05% Preservative-Free Fixed Combination Compared with Dorzolamide/Timolol Preservative-Free Fixed Combination and 2-Bottle Unfixed Combinations for the Treatment of Primary Open-Angle Glaucoma in the United KingdomHirst, A. / Almond, C. / Brereton, N. J. / Shergill, S. / Wong, W. et al. | 2013
- A507
-
Cost-Effectiveness of Sequences of Biologic Treatments for Moderate-To-Severe Psoriasis in FinlandAsseburg, C. / Valgardsson, S. / Soini, E. J. et al. | 2013
- A508
-
The Burden Imposed by Atopic Dermatitis on Families: Creation of a Specific QuestionnaireTaieb, C. / Branchoux, S. et al. | 2013
- A509
-
Quality of Life of Patients Suffering from Exudative Age-Related Macular Degeneration and Treated by Intravitreal Injections and Its Predictors: The Equade StudyLeveziel, N. / Joubert, M. / Hermans, M. / Moser, E. / Le Picard, S. / Maurel, F. et al. | 2013
- A511
-
Adherence by Spanish Retinologists to the Guidance for the Management of Patients with Wet Age-Related Macular DegenerationColomé, A. / Balaña, M. / Ruiz Moreno, J. M. / Roura, M. et al. | 2013
- A512
-
High Dosages of Statins in High Cardiovascular Risk Patients in a Real World Setting: Treatment Patterns and OutcomesDegli Esposti, L. / Sangiorgi, D. / Buda, S. et al. | 2013
- A513
-
Venous Thromboembolism in Gynae-Oncology Patients Post Surgery – Is Tinzaparin Prophylaxis an Effective Anticoagulant?Ibrahim, N. / Norris, L. / O’Toole, S. / Gleeson, N. et al. | 2013
- A514
-
Indirect Comparisons of Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: A Systematic Literature ReviewClaflin, A. B. / Liu, X. / Phatak, H. et al. | 2013
- A515
-
Anticoagulant Use in Hospitalized Patients with Acute Venous Thromboembolism in the United StatesLiu, X. / Xie, L. / Phatak, H. / Mardekian, J. / Tan, W. / Baser, O. / Schneider, R. F. / Ramacciotti, E. et al. | 2013
- A518
-
A Budget Impact Analysis to Estimate the Economic Impact of Drug Eluting Balloon for the Treatment of Peripheral Vascular DiseaseCorbo, M. / Beccagutti, G. / Manda, B. et al. | 2013
- A519
-
Pharmacoeconomic Benefits of Citicoline in the Treatment of Acute Ischemic Stroke in RussiaRyazhenov, V. V. / Gorokhova, S. G. et al. | 2013
- A520
-
The Burden of Resistant Hypertension in 5 European CountriesSapoval, M. / Hale, B. C. / Armstrong, S. / Da Deppo, L. / Hertz, D. / Briggs, A. et al. | 2013
- A521
-
Follow-On Health Care Costs in Patients with Acute Coronary Syndrome (ACS)Berger, A. / LaPensee, K. / Oster, G. et al. | 2013
- A523
-
Reanalyzing Using Bayesian Methods and Updated Data the Cost-Efectiveness Assumptions of Carotid Artery Stenosis TreatmentsSmolen, H. J. et al. | 2013
- A524
-
Cost-Effectiveness of Apixaban Versus Standard of Care for the Prevention of Stroke: An Analysis of Patients with Atrial Fibrillation in GreeceAthanasakis, K. / Arzoumanidou, D. / Karampli, E. / Armelidou, E. / Giovas, P. / Petrikkou, E. / Kyriopoulos, J. et al. | 2013
- A525
-
Cost-Effectiveness of Rivaroxaban in the Prevention of Stroke in Non-Valvular Atrial Fibrillation Patients in ItalyCapri, S. / Veneziano, M. / Ricciardi, W. G. / D’Ausilio, A. / Pedone, M. P. / Bianchi, C. et al. | 2013
- A526
-
The Cost-Effectiveness of Dabigatran and the Opportunity Cost of Delayed Subsidised Access in AustraliaTilden, D. / Germanos, P. / Gordon, J. / Tocchini, L. et al. | 2013
- A527
-
The Cost-Utility of Catheter-Based Renal Denervation as Compared to Current Standard of Care for Resistant Hypertension in BelgiumJugrin, A. V. / Caekelbergh, K. / Vanacker, J. / Vancauwenberghe, L. / Lamotte, M. et al. | 2013
- A528
-
Cost-Effectiveness Analysis of Ivabradine in Chronic Heart Failure in the Polish SettingBorowiec, L. / Faluta, T. / Filipiak, K. J. / Niewada, M. / Wrona, W. et al. | 2013
- A529
-
Economic Evaluation of Apixaban for the Prevention of Stroke in Atrial Fibrillation in the NetherlandsStevanovic, J. / Pompen, M. / Le, H. H. / Rozenbaum, M. H. / Postma, M. J. et al. | 2013
- A530
-
Cost-Utility Analysis of Coronary Artery Calcium Score to Guide Statin Therapy in Patients with Elevated C-Reactive Protein and Low LDL Cholesterol LevelsSilva Miguel, L. / Ferreira, A. M. et al. | 2013
- A531
-
Real World Resource Use Associated with Transcatheter Aortic Valve Implantation and Conventional Aortic Valve Replacement SurgeryAwad, W. / Mathur, A. / Baldock, L. / Oliver, S. / Kennon, S. et al. | 2013
- A532
-
Effects of the Occurrence of a First Cardiovascular Event on Statin Adherence in Type 2 Diabetes: A Matched Cohort Designde Vries, F. M. / Denig, P. / Vegter, S. / Bos, H. J. / Postma, M. J. / Hak, E. et al. | 2013
- A533
-
The Relation Between the Modified Rankin Scale (mRS) Scores and Utility Weights: Results from a Survey Among Community Dwelling Long Term Stroke SurvivorsGreenberg, D. / Ginsberg, G. / Ziv, A. / Litmanovitch-Goldstein, D. / Tanne, D. / Chodick, G. / Balicer, R. D. / Dankner, R. et al. | 2013
- A534
-
A Retrospective Study Comparing Compliance, Persistence, and Blood Pressure Control Between Free-Drug and Single-Pill Combination Therapies in Korean Hypertensive PatientsHong, J. M. / Kim, E. G. / Min, K. / Min, J. / Shin, K. / Yang, B. M. et al. | 2013
- A535
-
Coronary Artery Disease, Diabetes, and Health-Related Quality of Life: Findings of a Cohort Study from IndiaShah, B. S. / Deshpande, S. S. et al. | 2013
- A536
-
Adherence to Warfarin Treatment in Brazil: Systematic Review of the LiteratureFeijo, L. F. / Clark, O. A. / Monteiro, R. C. / Fujii, R. K. / Donato, B. M. / Bernardino, G. D. / Barbieri, D. E. / Mould, J. / Manfrin, D. F. et al. | 2013
- A537
-
Cross-Country Comparison of Prescribing Patterns Versus Portugal and Potential Cost-SavingsCosta, S. / Guerreiro, J. P. / Baptista, A. / Teixeira, I. / Torre, C. et al. | 2013
- A538
-
Analysis of Re-Hospitalisations for Stroke and Transient Ischemia Recurrence and Associated Costs in the Burgundy Region in FranceMarty, R. / Jouaneton, B. / Giroud, M. / Mougin, P. / Roze, S. et al. | 2013
- A539
-
The Volume-Outcome Relationship and Minimum Volume Standards – Empirical Evidence for GermanyMennicken, R. / Hentschker, C. et al. | 2013
- A540
-
Divergence of HTA Decisions Across Countries: Case Analysis of IvabradineThivolet, M. / Rémuzat, C. / Kornfeld, A. / Toumi, M. et al. | 2013
- A541
-
Results from the “Autor†Study, a European Observational Study in Pediatric Patients with Attention-Deficit/Hyperactivity DisorderHaynes, V. / Lopez-Romero, P. / Anand, H. et al. | 2013
- A542
-
Comparative Efficacy and Metabolic Side Effects of Lurasidone for the Management of Acute Schizophrenia: A Systematic Literature Review and Mixed Treatment Comparison with First and Second Generation AntipsychoticsGuelfucci, F. / Watt, M. / Vimont, A. / Roïz, J. / Cadi-Soussi, N. et al. | 2013
- A543
-
Patient-Reported Cognitive Dysfunction Negatively Impacts Functioning in Patients with Major Depressive Disorder – Preliminary Findings from the Perform StudySaragoussi, D. / Haro, J. M. / Boulenger, J. P. / Jönsson, B. / Knapp, M. / Caillou, H. / Chalem, Y. / Milea, D. / François, C. et al. | 2013
- A544
-
Assessing the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with Post-Traumatic Stress Disorder in the United StatesXie, L. / Dysinger, A. H. / Wang, L. / Du, J. / Huang, A. / Baser, O. et al. | 2013
- A545
-
Schizophrenia and Negative Symptoms – Burden of the Disease in Seven Central and Eastern European (CEE) Countries: THE Results of the Literature ReviewWalczak, J. / Augustyńska, J. / Miernik, K. / Stelmachowski, J. / Pieniazek, I. / Obrzut, G. / Pogroszewska, A. / Szkultecka-Debek, M. / Paulic, G. / Maric, D. et al. | 2013
- A546
-
Register Based Analysis of Treatment Costs of Second Generation Antipsychotics in SchizophreniaBorsi, A. / Takacs, P. / Feher, L. et al. | 2013
- A547
-
How Should an Antidepressant with Reduced Risk of Sexual Dysfunction Be Positioned in Treatment Strategies for Patients with Major Depressive Disorder?Massetti, M. / Vataire, A. L. / Cristeau, O. / Toumi, M. / Aballea, S. et al. | 2013
- A549
-
Comparison of Health Care Resource Utilization and Costs Among Children and Adolescents with Attention Deficit Hyperactivity Disorder in Germany Who Initiated Treatment with Atomoxetine or Long-Acting MethylphenidateCurtice, T. G. / Greven, P. / Yeaw, J. / Sikirica, V. / Chen, Y. J. / Setyawan, J. / Makin, C. et al. | 2013
- A550
-
Prevalence and Risk Factors of Depression in Patients with Chronic Obstructive Pulmonary Disease in IndiaNegi, H. / Raval, A. / Malay, M. et al. | 2013
- A551
-
Developing an Individualized E-Health Decision Support System for Dementia Treatment and Care: The FP7 EU-Project E-Health Monitor (EHM)Schaller, S. U. / Kriza, C. / Niederländer, C. / Wahlster, P. / Kolominsky-Rabas, P. L. et al. | 2013
- A552
-
Patients’ Characteristics and Patterns of Use of Depot Antipsychotics in Swedish Patients with SchizophreniaDepont, F. / Rouleau, A. / Osby, U. / Sobocki, P. / Milea, D. et al. | 2013
- A553
-
Impact of Autism Spectrum Disorders on the Family – A National PerspectiveVohra, R. / Madhavan, S. / Sambamoorthi, U. et al. | 2013
- A554
-
The Impact of Commodities and Extra-Articular Manifestations in Rheumatoid Arthritis PatientsDoddapaneni, S. / Khera, K. / Prabhu, V. A. / Nagappa, A. N. / Rau, N. R. et al. | 2013
- A556
-
Comparative Effectiveness of Active Versus Sham Acupuncture Versus Usual Care in the Management of Chronic, Non-Cancer Pain in Primary CareSaramago, P. / Weatherly, H. / Manca, A. / Sculpher, M. J. / MacPherson, H. et al. | 2013
- A558
-
Potential Economic Impact of Using Sugammadex for the Routine Reversal of Neuromuscular Blockade in Russian Health Care SettingDerkach, E. V. / Avxentyeva, M. V. / Omelyanovsky, V. V. et al. | 2013
- A560
-
Work Productivity Loss Due to Rheumatoid Arthritis in Poland. Results of Cross-Sectional Study of Outpatients with Chronic Inflammatory Diseases and Comparison with Selected StudiesWladysiuk, M. / Bebrysz, M. / Rutkowski, J. / Haldas, M. / Fedyna, M. et al. | 2013
- A561
-
Biological Treatment Patterns and Associated Costs for Patients with Rheumatoid Arthritis in TaiwanWu, C. H. / Chuang, P. Y. / Tang, C. H. et al. | 2013
- A562
-
Cost-Effectiveness Analysis of Biological Disease-Modifying Antirheumatic Drugs in the Treatment of Russian Patients with Rheumatoid Arthritis Who Failed Previous Anti-Tnf-Alfa TherapyRyazhenov, V. V. / Emchenko, I. V. et al. | 2013
- A564
-
Current and Future Strategy for Osteoporosis Screening and Diagnostics: Cost-Effectiveness of Frax with or without Pulse-Echo Ultrasound Measurement of Bone Mineral Density and DXA on DemandAsseburg, C. / Riekkinen, O. / Karjalainen, J. K. / Kröger, H. / Soini, E. J. et al. | 2013
- A566
-
Resource Use Due to Disability in Polish Rheumatoid Arthritis Patients: Significant Increase of Transportation Needs and Home VisitsSzafraniec-Burylo, S. I. / Orlewska, E. / Rupinski, R. / Filipowicz-Sosnowska, A. et al. | 2013
- A567
-
Persistence & Compliance to Treatment for Osteoporosis in Postmenopausal Women in Hungary: A Retrospective Cohort StudyLakatos, P. / Tóth, E. / Cina, Z. / Lang, Z. / Psachoulia, E. / Intorcia, M. et al. | 2013
- A568
-
Are Patients’ Preferences for Osteoporosis Drug Treatment Transferable Between Countries? Results from a Discrete-Choice Experiment Conducted in Two European CountriesHiligsmann, M. / Dellaert, B. / Dirksen, C. / Van der Weijden, T. / Goemaere, S. / McGowan, B. / Reginster, J. Y. / Watson, V. / Boonen, A. et al. | 2013
- A569
-
Health Outcomes and Economic Burden of Post-Knee Replacement Surgery in Osteoarthritis Patients: Comparison with Matched ControlsPignot, M. / DiBonaventura, M. et al. | 2013
- A570
-
Factors Associated with Absenteeism in Rheumatoid Arthritis Patients in Employment: Results of a Survey Among French PatientsFagnani, F. / Duburcq, A. / Woronoff, A. S. / Chauvin, P. / Cukierman, G. / Tropé-Chirol, S. / Joubert, J. M. / Bertin, P. et al. | 2013
- A571
-
Patterns of Disease Remission Among Patients with Rheumatoid Arthritis Receiving Their First Biologic in European UnionNarayanan, S. / Baskett, A. / Lu, Y. / Hutchings, R. et al. | 2013
- A572
-
Real World Utilization of Biological Agents in Rheumatoid Arthritis Patients: A French National Claims Database Analysis Over the Period 2009-2011Fautrel, B. / Laurendeau, C. / Joubert, J. M. / Cukierman, G. / Gourmelen, J. / Fagnani, F. et al. | 2013
- A573
-
The Resource Use Related to Hip Fractures Based on Data from ICUROSWintzell, V. / IvergÃ¥rd, M. / Tankó, L. B. / Barghout, V. / Svedbom, A. / Alekna, V. / Bianchi, M. L. / Clark, P. / DÃaz Curiel, M. / Dimai, H. P. et al. | 2013
- A574
-
The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in GermanySroczynski, G. / Esteban, E. / Engel, J. / Hillemanns, P. / Petry, K. U. / Krämer, A. / Schnell-Inderst, P. / Mühlberger, N. / Siebert, U. et al. | 2013
- A575
-
Threshold Selection in Biomarkers Using Cox Regression. An Application to Non-Small-Cell Lung CancerLuaces, P. / Sánchez, L. / Ballesteros, J. / GarcÃa, B. / RodrÃguez, P. C. / Viada, C. / Popa, X. / Crombet, T. / Lage, A. et al. | 2013
- A576
-
Review of Meta-Analysis Methods for Multinomial DataBennison, C. / van Beurden-Tan, C. / Buyukkaramikli, C. / Heeg, B. et al. | 2013
- A577
-
Physician Panels Supporting Clinical Trials and Post-Approval Studies in Oncology: A Willingness-To-Participate StudyPotthoff, P. / Brown, C. / Güther, B. / Eichmann, F. et al. | 2013
- A578
-
Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and WalesRighetti, C. / Lebmeier, M. / Pennington, B. / Brereton, N. J. et al. | 2013
- A579
-
Empirical Evidence for the Validity and Reliability of Resource-Use Measures Based on Patient Recall: A Systematic ReviewThorn, J. / Noble, S. / Moore, T. / Hollingworth, W. et al. | 2013
- A580
-
The Economic Footprint of the Greek Pharmaceutical IndustryTserkezis, E. / Paratsiokas, N. / Tsakanikas, A. / Athanasiadis, A. et al. | 2013
- A581
-
Use of the Clinical Practice Research Datalink (CPRD) to Assess ‘Real-World’ Management of Tuberous Sclerosis Complex (TSC) in the United KingdomDemuth, D. / Nasuti, P. / Richards, C. / Gray, L. / Price, L. / Magestro, M. et al. | 2013
- A582
-
Evaluation of Dissemination of Brazilian Network for Health Technology Assessment (REBRATS)Gonçalves, L. / Souza, K. M. / Elias, F. T. et al. | 2013
- A583
-
From Clinical Trial to Real-World Evidence: A Systematic Approach to Identifying Data Sources for Observational ResearchParasuraman, B. / Tomic, K. S. / Winchester, C. C. / Westergaard, M. / Johansson, S. et al. | 2013
- A585
-
Variance Reduction Through Antithetic Variates as a Means of Developing Complex VBA Models with Reasonable Computation TimesBennett, H. / Tetlow, A. P. / McEwan, P. et al. | 2013
- A587
-
The Role of Simulation Modeling in Planning Long-Term Clinical Trials in Type 2 DiabetesFoos, V. / Grant, D. / Palmer, J. L. / Lamotte, M. / McEwan, P. et al. | 2013
- A589
-
Literature Review and Assessment to Populate a Decision-Analytic Model Evaluating a Novel Prognostic in Early Lung CancerStenehjem, D. / Jiao, T. / Rhien, T. / Bellows, B. K. / Kaldate, R. R. / Jones, J. / Brixner, D. et al. | 2013
- A590
-
A De Novo Economic Model to Assess the Cost and Quality of Life Consequences of an Intervention for Levodopa Induced Dyskinesia Amongst Patients with Parkinson’s DiseaseBhattacharyya, S. / Sacco, P. / Shirore, R. M. / Sonathi, V. / Thomas, S. et al. | 2013
- A591
-
Appropriate Evidence Sources for Populating Decision Analytic Models Within Health Technology Assessment (HTA): A Systematic Review of HTA Manuals and Health Economic GuidelinesZechmeister-Koss, I. / Schnell-Inderst, P. / Zauner, G. et al. | 2013
- A592
-
The Role of Half-Cycle Correction in the Models Used for Health Technology AssessmentNemeth, B. / Vincziczki, . et al. | 2013
- A594
-
A Bayesian Dynamic Model of Asthma in the Real LifeAmzal, B. / Timmaraju, V. / Castelnuovo, E. / Boucot, I. / Pribil, C. / Nachbaur, G. et al. | 2013
- A595
-
Patient Preferences in the Choice of Disease Modifying Drugs for Multiple SclerosisBergmann, A. / Lang, M. / Bischoff, C. / Schicklmaier, P. / Schiffhorst, G. / Nolting, H. D. / Rellecke, J. / Kunz, E. et al. | 2013
- A596
-
Exploring the Feasibility of the Instrument Used in Determination of Willingness-To-Pay Per Quality-Adjusted Life-Year in MalaysiaLim, Y. W. / Shafie, A. A. / Hassali, M. A. / Chua, G. N. et al. | 2013
- A598
-
Pilot Testing of the Polish Pre-Final Version of “Disabilities of the Arm, Shoulder and Hand†(Dash) QuestionnaireGolicki, D. / Krzysiak, M. / Strzelczyk, P. et al. | 2013
- A599
-
Validity of QOL Impact Attributions to Specific Diseases: A Multitrait-Multimethod ComparisonWare, J. E. / Guyer, R. et al. | 2013
- A600
-
Patient-Reported Outcome Measures for Systemic Lupus Erythematosus Clinical Trials: A Content Validity and Psychometric Performance ReviewHumphrey, L. / Heron, L. / Pilling, C. / Holloway, L. / Højbjerre, L. / Strandberg-Larsen, M. / Hansen, B. B. et al. | 2013
- A602
-
A Review of Cognitive Interviewing Methodologies During Linguistic Validation of Clinical Outcome Assessments (COAs)Simon, M. / Sweeney, E. / Moravec, H. et al. | 2013
- A603
-
Parent Ratings of Ability to Consent for Clinical Trials in Fragile X SyndromeBailey, D. / Raspa, M. / Wheeler, A. et al. | 2013
- A604
-
Using Mobile Technology (mHealth) to Develop the Value Story for New Drugs, Devices and Therapies: Optimising User Engagement and Addressing Payer ConcernsTran, J. B. / Hugh-Jones, C. et al. | 2013
- A605
-
Development of a Questionnaire to Evaluate Food-Related Well-BeingGuillemin, I. / Allaert, F. A. / Arnould, B. / Capuron, L. / Dupuy, A. / Ginon, E. / Lecerf, J. M. / Prost, M. / Rogeaux, M. / Urdapiletta, I. et al. | 2013
- A606
-
Differential Item Functioning in a Satisfaction Item BankCampillo-Ã�lvarez, . / RodrÃguez-Aguilella, A. / Castejón, N. / Cuervo, J. / Rebollo, P. et al. | 2013
- A607
-
The Impact of DSM-5 on the Development of Drugs to Treat Attention-Deficit/Hyperactivity DisorderMeyers, O. I. et al. | 2013
- A608
-
Use of Multivariate Bayesian Evidence Synthesis to Reduce Uncertainty Around Clinical Effectiveness and Quality of Life EstimatesBujkiewicz, S. / Thompson, J. / Sutton, A. / Cooper, N. / Harrison, M. / Symmons, D. P. / Abrams, K. R. et al. | 2013
- A610
-
Adjusting for Treatment Switching in Clinical Trials When Only Summary Data Are Available – An Evaluation of Potential MethodsBoucher, R. / Abrams, K. R. / Crowther, M. J. / Lambert, P. C. / Wailoo, A. J. / Latimer, N. R. et al. | 2013
- A612
-
Research in Haemophilia B – Studies in a Rare Disease in Times of Requirements for High Evidence LevelsSchopohl, D. / Berger, K. / Schramm, W. et al. | 2013
- A613
-
Proposal of Economic Evaluation Guideline in JapanFukuda, T. / Akazawa, M. / Fukuda, H. / Igarashi, A. / Ikeda, S. / Ishida, H. / Kobayashi, M. / Moriwaki, K. / Noto, S. / Sakamaki, H. et al. | 2013
- A614
-
Systematic Review Approaches for HTA: Horses for Courses?Kenworthy, J. / Langham, J. / Chetty, M. et al. | 2013
- A615
-
Should There Be an Option to “Unrefer†Nice Single Technology Appraisals: Case Study of Aripiprazole for Bipolar I Disorder in AdolescentsUttley, L. / Kearns, B. / Stevenson, M. et al. | 2013
- A616
-
How Can Health Economic Assessment Methods Help Decision Making in Portfolio DevelopmentAkpo, H. / Popa, C. / Saka, . et al. | 2013
- A617
-
The Importance of Sensitivity Analyses in Health Technology AssessmentsHren, R. et al. | 2013
- A618
-
Effectiveness of the Early Psychosocial Intervention on Institutionalization of Patients with Mild Alzheimer’s Disease and Caregivers’ Quality of Life – An Alsova StudyMartikainen, J. A. / Kautiainen, H. / Väätäinen, S. / Välimäki, T. / Hongisto, K. / Hallikainen, I. / Sivenius, J. / Soininen, H. / Koivisto, A. et al. | 2013
- A619
-
Practice of Cerebroprotectors Consumption in UkraineKuznetsov, I. / Iakovlieva, L. / Ribka, A. / Vasileva, A. / Kyrychenko, O. et al. | 2013
- A621
-
The Annual Treatment and Rehabillitation Costs of Patients with Paraplegia in the Private Health Care Setting in GreeceTzovolou, K. / Geitona, M. et al. | 2013
- A622
-
Cost-Effectiveness of Somatropin Administration with Increased Adherence Due to Monitoring Compared to Non-Monitored Administration in Patients with Growth Hormone DeficiencyVitova, V. / Tichopad, A. et al. | 2013
- A623
-
Cost-Effectiveness Analysis of Lacosamide Compared with Standard of Antiepileptic Care Based on Clinical Practice DataVocelka, M. / Klimes, J. / Dolezal, T. / Foitova, H. et al. | 2013
- A624
-
Treatment Adherence and Costs in Multiple Sclerosis: A Narrative Review of the LiteraturePaz, S. / Comellas, M. / Lizán, L. et al. | 2013
- A625
-
Cultural Adaptation and Validation to Spanish of the “MS Treatment Concerns Questionnaire-MSTCQâ€Galera, J. / Munteis, E. / Navarro, G. / Meca, J. / Maestre, A. / Perez, A. / Gracia, J. / Pato, A. et al. | 2013
- A626
-
Evaluating Patient Adherence Rates to Approved Disease Modifying Therapies (DMT) for Relapsing-Remitting Ms (RRMS): Operational Setup for a Multi-Country, Multi-Center StudyApecechea de Scheffer, M. / Faber, S. / Potthoff, P. / Eichmann, F. et al. | 2013
- A627
-
Additional Clinical Benefit for Patient Relevant Endpoints: Investment Disincentives by AMNOG in the Example of Parkinson’s DiseaseWalzer, S. / Holbein, B. et al. | 2013
- A628
-
Drug Compliance and Persistence in Patients with Parkinson’s Disease Treated in Primary Care in the United Kingdom: A CPRD-Based StudyBineau, S. / Guelfucci, F. / Neine, M. / Aballea, S. / Milea, D. et al. | 2013
- A629
-
A Comparison of Demographic and Clinical Variables of Down Syndrome Patients in Utah and the United StatesJiao, T. / Liou, T. G. / Young, D. / Brixner, D. et al. | 2013
- A631
-
In-Patient Hospitalizations for Chronic Kidney Disease in the United StatesAggarwal, S. / Topaloglu, H. et al. | 2013
- A632
-
Cost and Cost-Effectiveness of Treating Urgency Stress Incontinence-Results from a Randomized Controlled TrialKafri, R. / Greenberg, D. / Shames, J. / Novack, L. / Melzer, I. et al. | 2013
- A633
-
Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United KingdomMaman, K. / Neine, M. / Briquet, B. / Nazir, J. / Odeyemi, I. A. / Hakimi, Z. / Garnham, A. / Aballéa, S. et al. | 2013
- A634
-
The Impact of Sacral Neuromodulation on EQ-5D Index Scores and Costs to Manage Overactive BladderHinnenthal, J. / Siegel, S. / Noblett, K. / Mangel, J. / Bird, E. T. / Griebling, T. L. / Comiter, C. et al. | 2013
- A635
-
Antibiotic Utilization in Complicated Urinary Tract Infection in a Tertiary Care Teaching Hospital in South IndiaNair, S. / Mathew, J. / Palaye, M. / Faryabi, R. / Shetty, P. / Shivshankar, K. / Thunga, G. / Vijayanarayana, K. et al. | 2013
- A637
-
ISPOR 16th Annual European Congress Disclosure Information| 2013
- A649
-
ISPOR 16th Annual European Congress Author Index| 2013
- A665
-
Utilidad De Biomarcadores Cardiacos (Point of Care Testing) En El Area De Urgencias Y Su Impacto EconómicoContreras, I. / Lopez-Perez, A. / Mendez, G. F. / Mejia-Arangure, E. et al. | 2013
- A666
-
Effect of Health Spending, Income Inequality and Margination Index on the Efficiency of the Health System in MexicoPinzon Florez, C. E. / Reveiz, L. / Idrovo, A. J. / Reyes, H. / Diaz de Leon, C. et al. | 2013
- A667
-
Eficácia E Segurança De Ranibizumabe E Bevacizumabe No Tratamento De Degeneração Macular Relacionada a IdadeSaturnino, L. T. / Silveira, M. R. / Guerra Junior, A. A. / Acurcio, F. D. et al. | 2013
- A668
-
Implications of Global Pricing Policies of Pharmaceuticals for Access the Innovative Drugs: The Case of Trastuzumab in Seven Latin American CountriesPichon Riviere, A. / Garay, U. / Augustovski, F. / Vallejos, C. / Huayanay, L. / Navia, M. D. / RodrÃguez, A. / Oliveira, C. / Andrade, C. J. / Buendia, J. A. et al. | 2013
- A669
-
¿Puede un Cambio del 2003 en el Reglamento en el Cuadro Básico (CBM) en México Impactar la Cantidad de Estudios CientÃficos Publicados de Evaluación Económica Completos de Medicamentos (EECM) en los Últimos 10 Años?Márquez Cruz, M. / Peralta Bácenas, L. A. / Ibarra Cázares, A. E. / Rodriguez Mendoza, M. M. / Pizarro Castellanos, M. / Soto Molina, H. et al. | 2013
- A670
-
Efecto Del Seguro Popular Salud Sobre La Demanda De Servicios Prenatales En El Contexto De La Cobertura Universal, México 2012Servan-Mori, E. et al. | 2013
- A671
-
A Multi-National Survey Assessing the Relationship Between Prophylaxis Treatment and Health-Related Quality of Life Among Severe Hemophilia a Patients in Latin AmericaPerez Bianco, P. R. / Berges, A. / Linares, A. / Moreno, B. / Arvizu, J. / Brabata, C. / Xiong, Y. / Ito, D. et al. | 2013
- A674
-
Fatores Associados À Compra De Medicamentos Em BrasÃlia: Uma Análise Econométrica Com Dados Transversais De Base PopulacionalAndrade, C. H. / Wichmann, R. M. / Galvao, T. F. / Pereira, M. G. / Silva, M. T. et al. | 2013
- A675
-
Crescimento De Óbitos Pós Partos Cesarianos No Brasil Versus Partos NormaisDrago, S. / Ferreira, C. N. / Salles, G. R. / Paloni, E. D. / Santana, C. F. / Souza, C. / Bonachela, F. / Abreu, A. A. et al. | 2013
- A676
-
Análisis De Costo-Efectividad De Los Profesionales De Enfermeria Con Experiencia Laboral En Uci Versus Sin Experiencia Laboral En El Error De La Medicación Parenteral En Pacientes Adultos Hospitalizados En UciBeiza, C. / Orrego, N. / Padilla, M. F. / Arriagada, M. J. / Catalan, J. / Fau, C. / Nasabun, V. et al. | 2013
- A677
-
Assessment of Adverse Events By Using Trigger Tools in Surgery Department of an Indian Tertiary Care Teaching HospitalVilakkathala, R. / Mallayasamy, S. / Konduru, S. / Rodriques, G. / Manchanapalli, P. / Rao, A. B. et al. | 2013
- A678
-
Comparación Del Trabajo En Equipo En Salas De CirugÃa Entre Un Hospital Privado Y Uno Público De Bogotá, D.CAmaya Arias, A. C. / Eslava-Schmalbach, J. / Barajas Sierra, R. et al. | 2013
- A679
-
Exploring Income Inequality in Self-Reported Health Status in Chile After the Health Care Reform of 2005Cabieses, B. / Espinoza, M. A. et al. | 2013
- A680
-
A Mediação De Conflitos Na Ação Fiscalizatoria Do Setor De Saúde Suplementar BrasileiroTanaka, F. H. / Franco, S. et al. | 2013
- A681
-
Access to Medicines Index: Measuring How Well Countries Provide Access to MedicinesShankar, R. / Hickson, S. / Gorokhovich, L. et al. | 2013
- A682
-
O Uso De Temozolomida No Tratamento De Astrocitoma De Baixo Grau – Câncer No CérebroGomes, R. M. / Ribeiro Júnior, N. G. / Costa, J. O. / Júnior, A. A. / Acurcio, F. A. et al. | 2013
- A684
-
Direct Medical Costs (DMC) of Treating Chronic Lymphoid Leukemia (CLL) Patients in the Private Health Care System in Brazil: Results from a 12-Month Retrospective Analysis of an Administrative DatabasePaloni, E. D. / Ferreira, C. N. / Asano, E. / Santana, C. F. / Pereira, M. L. et al. | 2013
- A685
-
Análisis De Costo-Efectividad De Erlotinib En El Tratamiento De Pacientes Con Cáncer Pulmonar De Células No Pequeñas, CPCNP, Con Mutación Del Gen EGFR+, En Colombiaparada Vargas, L. A. / Barbosa, D. A. et al. | 2013
- A686
-
Tratamento Do Câncer Colorretal Metastático Com Bevacizumabe E Cetuximabe: Acesso E Impacto Econômico Em Um Hospital UniversitárioUngari, A. Q. / Pereira, L. R. / Nunes, A. A. / Peria, F. M. et al. | 2013
- A687
-
Comparación Indirecta De La Efectividad De La Combinación De Hipoglucemiantes Asociados a Metformina En Pacientes Diabéticos Tipo 2Sanchez, O. / Romero, M. et al. | 2013
- A688
-
Direct Costs of Type 2 Diabetes in Mexico from the Public Health Care Sector PerspectiveChatzitheofilou, I. / Babineaux, S. M. / RamÃrez-Gámez, J. / McDonell, A. / Vega-Hernandez, G. et al. | 2013
- A689
-
A Health Economic Analysis of the Long-Term Outcomes and Costs Associated with Using Canagliflozin Versus Sitagliptin As an Add-On to Metformin (MET) in MexicoTeschemaker, A. R. / Neslusan, C. / Puig, A. / Valencia, A. / Johansen, P. / Willis, M. et al. | 2013
- A690
-
Impacto De La Diabetes Sobre La Productividad En ArgentinaAsteazaran, S. / Elgart, J. / Gagliardino, J. J. et al. | 2013
- A691
-
Influence of One Week Education Program on the Knowledge and Approach of Pharmacy Students Towards Diabetes MellitusKhan, M. S. / Akhtar, N. / Ali, A. et al. | 2013
- A692
-
Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in ChileGarcia Marti, S. / Alcaraz, A. / Valanzasca, P. / Garay Ulises, U. / McMullen, M. / Rey Ares, L. / Peirano, I. / Oksenberg Reisberg, D. / Soza Ried, A. / Poniachik, J. et al. | 2013
- A693
-
Evaluation of Factors Affecting Treatment Response and Risk Factors for Patients Diagnosed with Non-Psychotic Major Depressive Disorder: A Literature ReviewGreene, N. / Greene, M. et al. | 2013
- A694
-
The Impact of Antipsychotics Polypharmacy on Health Care Costs of People with Mental Disorders in São Paulo City, BrazilRazzouk, D. / Sousa, A. / Oliveira, G. G. / Cardoso, A. / Mari, J. J. et al. | 2013
- A695
-
Contribution of Latin America to Mental Health in PregnancyLorenzo, L. S. / Einarson, A. / Einarson, T. R. et al. | 2013
- A696
-
Costo-Efectividad Del Screening Y Tratamiento De Hipoacusia Bilateral En Recién Nacidos (Rn) En ChileCastillo-Laborde, C. / Loayza, S. / Aravena, M. / Freile, B. / Castillo-Riquelme, M. et al. | 2013
- A697
-
Impacto Presupuestal De La Enfermedad Renal Terminal En Colombia Con Un Incremento Del Número De TrasplantesRosselli, D. / Rueda, J. D. / DÃaz, C. E. et al. | 2013
- A698
-
Cost-Effectiveness Analysis of Rabbit Antithymocyte Globulin Compared to Basiliximab in the Induction of Renal Transplant PatientsEscudero, P. / Misas, J. D. / Orozco-Cabal, L. F. et al. | 2013
- A699
-
Estudios Del Coste De La EnfermedadCrespo, C. / Gisbert, R. / Brosa, M. et al. | 2013
- A700
-
Analysis of Mandibular Test Specimens Used to Evaluate Bone Fixation SystemsPasseri, L. A. / Baccarin, L. S. / Casarin, R. C. / Silva, J. V. et al. | 2013
- A701
-
Disponibilidad Y Fuentes De La Información Para La Toma De Decisiones En ReumatologÃa: Uso De Los Estudios EconómicosGuzman Vazquez, S. / Rodriguez Mendoza, M. M. / Pizarro, M. / Soto, H. et al. | 2013
- A702
-
Permanent Transvenous Lead Extraction: Factors Influencing the Difficulty of the ProcedureBontempi, L. / Cerini, M. / Lipari, A. / Vassanelli, F. / Salghetti, F. / Locantore, E. / Belotti, M. / D’Aloia, A. / Vizzardi, E. / Raweh, A. et al. | 2013
- A703
-
Analysis of Consumption of Antihypertensive Drugs in Serbia from 2007 to 2011Milijasevic, B. / Milijasevic, D. / Tomic, Z. / Sabo, A. / Mikov, M. / Tomic, N. et al. | 2013
- A704
-
Cost Analysis of Pulmonary Arterial Hypertension in a Tertiary Care Setting in Mexico CityRely, K. / RamÃrez-Neria, P. / Pulido, T. / Escamilla, C. / Alexandre, P. K. / Cañedo, A. / Salinas Escudero, C. et al. | 2013
- A705
-
Cost-Effectiveness of Transcatheter Aortic-Valve Implantation for Severe Symptomatic Aortic Stenosis in Inoperable Patients in the Brazilian Public Health Care SystemNishikawa, A. M. / Paladini, L. / Borges, L. / Queiroga, M. / Lemos, P. / Clark, O. A. et al. | 2013
- A706
-
Correlación Entre Los Niveles De LDL-C Frente Al Riesgo De Presentación De Evento CardiovascularSimbaqueba, E. / Romero, M. et al. | 2013
- A707
-
Estimating the Impact of Statin Therapy on Direct and Societal Costs in Mexico: A Comparison to SwedenSemilla, A. P. / Kowal, S. / Storm, M. / Blanchard, T. et al. | 2013
- A708
-
Análise Comparativa Dos Anticoncepcionais Orais Com Diferentes Concentraçoes De Etinilestradiol Em Relação Aos Perfis De Eficácia E De AdesãoFreitas, M. G. / Silva, A. S. / Elias, F. T. et al. | 2013
- A709
-
Costo-Efectividad De Carbetocina En Comparación Con Oxitocina Para Prevenir Hemorragia Posparto Por AtonÃa Uterina En Pacientes Con Factores De Riesgo En ColombiaRueda, C. / Caceres, L. A. / Caicedo Navas, A. G. et al. | 2013
- A710
-
Measurements of Adherence to Oral Therapies Among Brazilian Patients: A Systematic ReviewTakemoto, M. L. / Guerra, R. / Fernandes, R. A. / Pereira, A. C. / Santos, P. M. / Amaral, L. M. / Vasconcellos, J. F. et al. | 2013
- A711
-
Atención Intercultural Del Parto Vaginal En México: Costos Económicos, Determinantes Y Retos De La Implementación De PolÃticas Efectivas En Beneficio De Las Mujeres IndÃgenasHeredia, I. / Meneses, S. / Montag, D. / Ibañez, M. / Hernández, E. / González Block, M. A. et al. | 2013
- A712
-
Costos Económicos Asociados A Secuelas De Meningitis En ColombiaAlvis-Guzmán, N. / Coronell-Rodriguez, W. / Castañeda-Orjuela, C. A. / De la Hoz-Restrepo, F. et al. | 2013
- A713
-
The Health and Economic Impact of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) in Columbia: A Transmission Dynamic Model-Based EvaluationKothari, S. / Nwankwo, C. / Pillsbury, M. / Shcheprov, A. / Posso, H. et al. | 2013
- A714
-
Pharmacoeconomics of Cervarix Vaccines Against Human Papilloma Virus in the Republic of KazakhstanNurgozhin, T. / Gulyaev, A. / Yermekbayeva, B. / Kushugulova, A. / Akhmetova, A. / Supiev, A. et al. | 2013
- A715
-
Avaliação Do Impacto Orçamentário Com a Incorporação De Imunobiológicos Em Uma Operadora De Planos De Saúde – 2012Reis, H. P. / Magalhães, D. D. / Vieira, J. B. / Sartori, D. P. / Fonseca, D. B. / Filho, A. E. / Barsi, U. D. / Gontei, M. / Alcantara, A. C. / Maciel, J. A. et al. | 2013
- A716
-
Custos Das Fraturas Osteoporóticas No Sistema Público De Saúde BrasileiroBrandão, C. M. / Machado, G. P. / Drumond, H. A. / Alemão, M. M. / Acurcio, F. D. et al. | 2013
- A717
-
Estimated Cost Effectiveness of Lower-Dose Submicron Diclofenac Compared with Traditional Diclofenac in BrazilMladsi, D. M. / Ronquest, N. / Tannus, G. / Fonseca, M. / Saag, K. et al. | 2013
- A718
-
Qualidade De Vida Dos Pacientes Que Utilizam Medicamentos Anti-TNF Para O Tratamento De Doenças Reumáticas No Sistema Único De Saúde Em Minas Gerais, BrasilOliveira Junior, H. A. et al. | 2013
- A720
-
Burden of Multiple Sclerosis and Unmet Needs in Brazil: Cost of Illness StudySilva, N. L. / Takemoto, M. / Damasceno, B. / Fragoso, Y. D. / Finkelsztejn, A. / Gomes, M. et al. | 2013
- A721
-
Cost-Effectiveness Analyses of Natalizumab for 1st Line Versus Interferon Beta-1a 44 Mcg in the Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis Patients in BrazilNishikawa, A. M. / Paladini, L. / Liamas, A. L. / Bueno, C. C. / Clark, O. A. et al. | 2013
- A722
-
Evaluation of Treatment Patterns and Clinical Trials Published on Patients Diagnosed with Insomnia: A Literature UpdateGreene, N. / Greene, M. et al. | 2013
- A723
-
Health and Economic Burden of Tobacco Use in Seven Latin American Countries: Results from a Microsimulation Health Economic Model (HEM)Pichon Riviere, A. / Bardach, A. / Caporale, J. / Augustovski, F. / Alcaraz, A. / Navia, M. D. / Pinto, M. / Vallejos, C. / Peña Torres, E. / Reynales, L. M. et al. | 2013
- A725
-
Efficacy and Safety of Belimumab for the Treatment of Systemic Lupus ErythematosusBorba, H. H. / Wiens, A. / Correr, C. J. / Pontarolo, R. et al. | 2013
- A726
-
Análisis Costo-Efectividad Del Tratamiento Farmacológico Para Las Manifestaciones ClÃnicas Mucocutáneas De La Enfermedad De BehcetQuirland Lazo, C. et al. | 2013
- A727
-
Orphan Drug Access: Risk/Reward Analysis of Local Clinical Development in ChileIsmail, A. / Dummett, H. et al. | 2013
- A729
-
ISPOR 4th Latin America Conference Disclosure Information| 2013
- A732
-
ISPOR 4th Latin America Conference Author Index| 2013
- i
-
Table of Contents| 2013
- I
-
Instructions for Authors| 2013
-
Incremental Cost Per Quality-adjusted Life Year Gained? The Need for Alternative Methods to Evaluate Medical Interventions for Ultra-rare DisordersSchlander, M. / Garattini, S. / Kolominsky-Rabas, P. / Nord, E. / Persson, U. / Postma, M. / Richardson, J. / Simoens, S. / Sola Morales, O. / Tolley, K. et al. | 2013
-
A Methodology for Predicting the Impact of Copayments on the Utilization of Health TechnologiesSabatelli, L. et al. | 2013
-
Variability in Hybrid Drug Availability and Pricing in EuropeFlostrand, S. J. / Lor, S. / Hughes, A. L. et al. | 2013
-
Level and Factors Impacting the Patient Dissatisfaction in the Primary Care Visits Based on the Cross-Section Measurement – a Prospective Finnish StudySoini, E. J. / Koskela, T. / Kangaspunta, V. / Ryynänen, O. P. et al. | 2013
-
Management of Obese Women During Pregnancy Across Europe According to Clinical Practice GuidelinesCallejo, D. / DÃaz-Cuervo, H. / Fernández-Ortiz, L. / Rebollo, P. / Simmons, D. / van Poppel, M. et al. | 2013
-
Cost-Effectiveness of Caspofungin Versus Voriconazole for Empiric Therapy in TurkeyTurner, S. J. / Senol, E. / Kara, A. / Al-Badriyeh, D. / Kong, D. C. / Dinleyici, E. C. et al. | 2013
-
Cost-Effectiveness Analysis (CEA) of Linezolid Versus Vancomycin in the Treatment of Nosocomial Pneumonia Caused by Methicillin-Resistant Staphylococcus Aureus (MRSA-NP) Based on a Phase IV Clinical Trial: Results from Four Major Cities in ChinaWan, Y. / Wang, X. / Wu, B. / Kang, H. / Li, Q. / Chen, Y. / Li, J. Z. / Liu, S. / Gao, X. et al. | 2013
-
Economic Evaluation of Fluoroquinolone-Based Regimens for the Treatment of Community-Acquired Pneumonia in a Multi-Field Hospital in RussiaKozlov, R. S. / Dekhnich, A. V. / Ratchina, S. A. / Belkova, Y. A. et al. | 2013
-
What Clinical Benefits Could Be Expected from the Implementation of a Rotavirus Vaccination Programme in France?Yamin, D. / Remy, V. / Atkins, K. E. / Galvani, A. P. et al. | 2013
-
Systematic Review of Colistimethate Sodium Dry Powder and Tobramycin Dry Powder Antibiotics for Pseudomonas Aeruginosa Lung Infection in Cystic FibrosisHarnan, S. E. / Uttley, L. / Cantrell, A. / Taylor, C. J. / Walshaw, M. / Brownlee, K. / Tappenden, P. et al. | 2013
-
Effectiveness of Montelukast on Asthma Control in Infants: Methodology of a Claims Data StudyBelhassen, M. / Tamberou, C. / Laigle, V. / Souchet, T. / Chanut-Vogel, C. / Lamezec, L. / De Blic, J. / Brouard, J. / Fauroux, B. / de Pouvourville, G. et al. | 2013
-
Health Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease in North IndiaNegi, H. / Sarkar, M. / Raval, A. et al. | 2013
-
Examining the Burden of Illness of Veteran Patients Diagnosed with Obesity in the United StatesWang, L. / Xie, L. / Du, J. / Li, L. / Baser, O. et al. | 2013
-
Mortality and Survival in Inoperable or Residual/Recurrent Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Systematic Literature ReviewByrnes, M. J. / Ashaye, A. O. / Iheanacho, I. / Travers, K. / Sikirica, M. et al. | 2013
-
A Budget Impact Model for Novoseven for the Management of Bleeding Episodes in Patients with Haemophilia a Treated with InhibitorsKaskens, L. / Martial, L. / Montoro Ronsano, J. B. / Ramirez de Arellano, A. / Darba, J. et al. | 2013
-
Exploring the Burden of Illness of Hereditary Angioedema in the United KingdomHelbert, M. / Drogon, E. / Mannan, A. / Holbrook, T. / Murray, H. / Piercy, J. et al. | 2013
-
Cost-Effectiveness Analysis of Cysteamine in the Treatment of Patients with Cystinosis – a Rare DiseaseWalczak, J. / Stelmachowski, J. / Obrzut, G. / Hubert, A. et al. | 2013
-
Supplementary Health Insurance in TurkeyDeger, C. C. / Tuna, E. / Ozdemir, Z. / Ozel, M. O. / Parali, E. / Sumer, F. / Yilmaz, Z. S. et al. | 2013
-
Is It Worth Having Orphan Drug Status in Germany Post-Amnog?Radicek, S. / Obradovic, M. / Rauland, M. et al. | 2013
-
Therapy Sequences in Multiple Myeloma – A Clinical Model Study in Regards of a German Cost ContextWirth, D. / Loellgen, N. / Knop, S. et al. | 2013
-
Conditional Survival (CS) Probabilities for Advanced Melanoma Patients Treated with Ipilimumab: Model Based AnalysisLee, D. / Kotapati, S. / Gueron, B. / Bapat, U. / Batty, A. J. et al. | 2013
-
Health Economic Evaluation of a Complementary Biomarker for Hypothetical Prostate Cancer Screening in GermanyMeier, F. / Niederländer, C. S. / Djanatliev, A. / Gantner-Bär, M. / Höllthaler, J. / Voigt, W. / Schöffski, O. / Kolominsky-Rabas, P. L. / Emmert, M. et al. | 2013
-
Analysis of Public and Private Hospital Databases (PMSI) 2010 / 2011 to Estimate the Frequency and Associated Costs for Febrile Neutropenia in FranceVainchtock, A. / Cohen, S. / Durand-Zaleski, I. et al. | 2013
-
Early-Stage Economic Evaluation of Stratified Medicine in Multiple MyelomaGaultney, J. G. / Redekop, W. K. / Sonneveld, P. / van der Holt, B. / Uyl-de, G. r. et al. | 2013
-
An Overview of Domestic Cancer Drugs in Turkey: 2008-2012Vural, E. H. / Safak Yilmaz, E. / Vural, I. M. / Dogan, E. / Akbulat, A. / Gursoz, H. / Kerman, S. et al. | 2013
-
Short-Term Disability (STD) Associated with Skeletal Related Events (SRES) in Commercially Insured Patients with Bone Metastases (BM) Secondary to Solid TumorsQian, Y. / Song, X. / Zhang, K. / Balakumaran, A. / Arellano, J. et al. | 2013
-
Workforce Participation and Productivity Losses After Head and Neck CancerPearce, A. M. / Timmons, A. / Hanly, P. / O’Neill, C. / Sharp, L. et al. | 2013
-
Hospital Resources Consumption Associated with Trastuzumab Treatment in Breast Cancer in PortugalAndrade, S. / Santos, A. et al. | 2013
-
Changes in Patient-Reported Outcomes Among Pediatric Leukemia and Lymphoma Patients During the First 2-Years Post Allogeneic Stem Cell Transplantation (alloSCT)Oberg, J. A. / Morris, E. / Cairo, M. / Kelly, K. M. et al. | 2013
-
An Exploratory Analysis of the Association Between EORTC-QLQ C30 Domains and Progression Free/Overall Survival in Advanced Melanoma After 12 Weeks of Treatment on Ipilimumab Compared to Gp100 in a Phase III Clinical TrialLee, D. / Harvey, B. / Gaudin, A. F. / Gueron, B. / Bregman, B. / Lebbe, C. / Bonnetain, F. / Borget, I. et al. | 2013
-
Cancer Patients May Have a Different Point of View on Oncology Drug Coverage Decisions Than Non-PatientsFoley, K. / Hansen, L. G. et al. | 2013
-
Treatment Patterns of Chronic Lymphocytic Leukemia Patients Under the Brazilian Public Health Care PerspectiveVitale, V. / Asano, E. / Rego, M. A. / Pereira, M. L. et al. | 2013
-
Retrospective Analysis of Oncology Indications Utilizing Drug Expenditures from 2005 to 2012 in the Republic of SrpskaGuzvic, V. / Komjenovic, D. / Zah, V. et al. | 2013
-
Real Life Effects of Liraglutide Supports Those Shown in RCTsKarasik, A. / Heymann, A. D. / Sternberg, P. / Leshno, M. / Todorova, L. / Goldshtein, I. / Bergan, E. Q. et al. | 2013
-
Study and Evaluation of Medication Errors in Diabetic Patients in Medicine Ward of a Secondary Care Community Hospital at Mumbai, IndiaLokhande, A. K. / Patidar, D. / Patil, U. K. et al. | 2013
-
Estimation of the Cost of Complications Related to Glycated Hemoglobin in the Italian Diabetes Type 1 PopulationNicolucci, A. / de Portu, S. / Orsini Federici, M. / D’Ostilio, D. et al. | 2013
-
Assessment of Real-World Usage of Lanreotide (Somatuline Autogel) 120 Mg in Polish Acromegalic Patients – Results from 1 Year Prospective Phase of Lanro-StudyOrlewska, E. / Kos-Kudla, B. / Sowinski, J. / Sworczak, K. / Zgliczynski, W. et al. | 2013
-
Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlandsvan Haalen, H. G. / Pompen, M. / Bergenheim, K. / McEwan, P. / Townsend, R. / Roudaut, M. et al. | 2013
-
The Diabetic Peripheral Neuropathic Pain Impact (DPNPI) Measure – Psychometric Validation of a New Patient Reported Outcome MeasureBrod, M. / Ramasamy, A. / Bushnell, D. M. / Blum, S. I. et al. | 2013
-
Assessing the Relationship Between the Diabetes Health Profile and Diabetes Specific Clinical Indicators: Case for Tailored TherapeuticsMulhern, B. / Meadows, K. / Churchman, D. et al. | 2013
-
Three-Year Health Care Expenditures in Diabetic Patients Receiving Rapid-Acting Insulin Analogues Versus Those on Human Regular InsulinCammarota, S. / Bruzzese, D. / Catapano, A. L. / Citarella, A. / De Luca, L. / Manzoli, L. / Masulli, M. / Menditto, E. / Mezzetti, A. / Riegler, S. et al. | 2013
-
To What Extent Can Biosimilars Compete with Brand Name Biologics? A EU-5 Granulocyte-Colony Stimulating Factors Markets AnalysisBocquet, F. / Paubel, P. / Fusier, I. / Cordonnier, A. L. / Le Pen, C. / Sinègre, M. et al. | 2013
-
Utilizing Storytelling to Promote Rational Antibiotic Use in 9-11 Years Old School Children in IranSoleymani, F. / Mohammadhosseini, N. / Mohammadzadeh, S. / Kazemi, M. et al. | 2013
-
Indirect and Direct Savings Resulted from Parallel Trade of Pharmaceuticals in Poland – Results of Valuation Sales Data from Public PharmaciesBaran-Lewandowska, I. / Hermanowski, T. et al. | 2013
-
Is External Price Referencing an Appropriate Drug Policy from an Efficiency, Equity, and Quality Perspective?Wouters, O. J. / Kanavos, P. et al. | 2013
-
Introduction of Innovations into the German Statutatory Reimbrusment System – Factors for SuccessKrensel, M. et al. | 2013
-
Understanding Patterns of Monitoring of Appropriate Prescribing in EuropeSchroeder, C. / Keja, J. / Hughes, B. / Toussi, M. et al. | 2013
-
The Implications of Demographic Changes for GMS Costs in Ireland Through to 2026Conway, A. / Kenneally, M. / Thummel, A. / Woods, N. / Ryan, M. et al. | 2013
-
The Transparency of National Health Care Costs in the ‘European Union Five (EU-5)’Firth, Z. A. / Smith, T. A. et al. | 2013
-
Medical Cards During Recession: How Many, for Whom and How Much?Kenneally, M. et al. | 2013
-
A Retrospective Analysis of Drug Reimbursement Decisions in Ireland: A Multi Criteria Decision Analysis ApproachSchmitz, S. / McCullagh, L. / Adams, R. / Barry, M. / Walsh, C. et al. | 2013
-
Biosimilar and Originator Biologic Pricing Dynamics in Emerging MarketsLockwood, C. / Reinaud, F. / Marinoni, G. / Ando, G. et al. | 2013
-
Evaluation of the Policies Implemented to Monitor Prescription and Reduce Pharmaceutical Expenditure at the University General Hospital of Patras, GreeceTsiata, K. / Letsios, A. / Kousoulakou, H. / Geitona, M. et al. | 2013
-
Cost-Outcome Description of Clinical Pharmacist Interventions in a University Teaching HospitalGallagher, J. / Mc Carthy, S. / Lynch, D. / Woods, N. / Byrne, S. et al. | 2013
-
Evaluate the Status of Pharmacoeconomic Research Development in China from 2002 to 2013Chen, C. I. / Huang, Y. et al. | 2013
-
Public Preference Elicitation in Drug Reimbursement Using Multi-Criteria Decision Analysis (MCDA) for Universal Health Insurance System in South KoreaCho, H. Y. / Lee, E. K. et al. | 2013
-
Impact of the German Amnog Evaluation on Drug Prices: Correlation of Rebate?Neeser, K. / Loeffler, D. / Schmidt, E. / Muller, E. et al. | 2013
-
A Comparative Study of the Role of Disease Severity in Drug Reimbursement Decision Making in Belgium, France, the Netherlands and SwedenFranken, M. / Koopmanschap, M. et al. | 2013
-
Towards Evidence-Based European Policy in Clinical Trials the Survey of Attitudes Towards Trial Sites in Europe - The SAT-EU StudyTmGehring, M. / Taylor, R. / Casteels, B. / Piazzi, A. / Mellody, M. / Gensini, G. F. / Ambrosio, G. et al. | 2013
-
Determinants of Prompt Access to Health Care in CHPS Programme in Rural Communities of Bawjiase, GhanaNuamah Buruwaa, G. / Agyei-Baffour, P. et al. | 2013
-
Are Monoclonal Antibodies Still Considered as Innovative by the French Health Care System? A Retrospective Analysis 2000-2012Conti, C. C. / Kostakis, A. / Furniss, S. J. et al. | 2013
-
A Comparison of German Benefit Assessments by G-Ba, IQWiG and ManufacturersEheberg, D. / Lebioda, A. / Hülsebeck, M. / Plantör, S. et al. | 2013
-
Use of Clinical Practice Guidelines by Physicians in JapanShimbo, T. / Suzuki, T. / Takahashi, O. / Tanaka, Y. et al. | 2013
-
Orphan Drug Legislations: Heyday or Had Their Day?Palmer, M. / Hughes, D. A. et al. | 2013
-
Incidence of Anastomotic Leaks After Colorectal Surgeries Using Hospital Episode Statistics in the United KingdomRiebman, J. / Lim, S. / Gao, X. / Delatore, P. / Wan, Y. et al. | 2013
-
Economic Consequences of Nonalcoholic Steatohepatitis in the United StatesLin, F. / Thomas, S. / Gruenberger, J. B. / Calado, F. et al. | 2013
-
An Economic Evaluation of the Triple HCV Treatment Regimen for G1 Naïve Patients in the Greek Health Care SystemAthanasiadis, A. / Konstantopoulou, T. / Koulouris, S. et al. | 2013
-
The Relationship Between Irritable Bowel Syndrome with Constipation Symptoms and Health-Related Quality of LifeBuono, J. L. / Taylor, D. C. / Spalding, W. M. / Carson, R. T. et al. | 2013
-
Inflammatory Bowel Diseases in Italy: Incidence Trends and Patients’ CharacteristicsFornari, C. / Madotto, F. / Fiorino, G. / Ardizzone, S. / Bortoli, A. / Caprioli, F. / Cestari, R. / Conti, S. / Cortelezzi, C. / Mantovani, L. G. et al. | 2013
-
Canadian Burden of Choroidal Neovascularization Secondary to Pathologic Myopia: Baseline Characteristics of PatientsZaour, N. / Heisel, O. / Barbeau, M. / Ma, P. et al. | 2013
-
A Quebec Economic Evaluation for 36 Months of Ranibizumab for the Treatment of Diabetic Macular EdemaHaig, J. / Barbeau, M. / Ferreira, A. / Pickering, M. et al. | 2013
-
Etanercept Provides Improved Quality of Life Regardless of the Presence of Psoriatric Arthritis in Moderate/Severe Psoriasis Subjects from Central and Eastern Europe, Latin America and AsiaKemeny, L. / Amaya, M. / Cetkovska, P. / Lee, W. R. / Galimberti, L. R. / Mahgoub, E. / Rahman, M. / Marshall, L. / Pedersen, R. / Tang, B. et al. | 2013
-
Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at Very High Cardiovascular Risk in the United Kingdom: Results from a General Practice Population StudyRay, K. K. / Foody, J. / Khan, I. / Lewis, B. E. et al. | 2013
-
The Humanistic and Economic Burden of Venous Thromboembolism in Pregnant Women: A Systematic ReviewKourlaba, G. / Milonas, C. / Kontodimas, S. / Holm, M. V. / Maniadakis, N. et al. | 2013
-
The Costs of Surgical Aortic Valve Replacement in FranceGoodall, G. / Candolfi, P. et al. | 2013
-
Application of New French Guidelines for Economic Evaluations: A Cost-Effectiveness Analysis of Apixaban in Patients with Non-Valvular Atrial Fibrillation in FranceDurand-Zaleski, I. / Cotté, F. E. / Lanitis, T. / Godard, C. / Kachaner, I. / Kongnakorn, T. / Gaudin, A. F. et al. | 2013
-
Cost-Effectiveness of Transcatheter Aortic-Valve Implantation for Severe Symptomatic Aortic Stenosis in Inoperable Patients in the Brazilian Private Health Care SystemNishikawa, A. M. / Paladini, L. / Queiroga, M. / Lemos, P. / Clark, O. A. et al. | 2013
-
Cost-Effectiveness of Increasing Statin Adherence for Primary and Secondary Prevention in Community PharmaciesVegter, S. / Oosterhof, P. / van Boven, J. F. / Stuurman-Bieze, A. G. / Hiddink, E. G. / Postma, M. J. et al. | 2013
-
International Normalized Ratio (INR) Monitoring and Percent Time in Therapeutic INR Range (TTR) Have Impact on Patient’s Quality of Life? Application of Beta Regressions in a Prospective 3 Months SettingSoini, E. J. / Koskela, T. / Ryynänen, O. P. et al. | 2013
-
Prescription Patterns of Antihypertensive Agents in T2DM Patients Visiting Tertiary Care Centre in North IndiaRaval, A. / Dhanaraj, E. / Bhansali, A. / Yadav, R. et al. | 2013
-
Assessing the Impact of Organized Screening for Abdominal Aorta Aneurysms in Austria – Following Eunethta Core InformationUrach, C. / Zauner, G. / Wilbacher, I. / Endel, G. / Miksch, F. / Breitenecker, F. et al. | 2013
-
Factors Associated with Early Response to Olanzapine and Clinical and Functional Outcomes of Early Responders Treated for Schizophrenia in ChinaYe, W. W. / Montgomery, W. / Kadziola, Z. / Liu, L. L. / Xue, H. B. / Treuer, T. et al. | 2013
-
Cost-Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in GermanyZeidler, J. / Mahlich, J. C. / Greiner, W. / Heres, S. et al. | 2013
-
Cost-Effectiveness of Asenapine Versus Atypical Antipsychotics Used in Turkey in the Treatment of Bipolar I DisorderPala, M. / Özdemir, S. / Ozdemir, O. et al. | 2013
-
C-Quality: A Cost and Quality of Life Pharmacoeconomic Analysis of Antidepressants in Major Depressive Disorder in ItalyKatz, P. / Heiman, F. / Ripellino, C. et al. | 2013
-
Cost-Utility Analyses of Cognitive-Behavioral Therapy for Major Depressive Disorder – A Systematic ReviewBrettschneider, C. / König, H. H. et al. | 2013
-
Budget Impact Analysis of Biosimilar Infliximab Treatment for Rheumatoid Arthritis in Six Central European CountriesBrodszky, V. / Péntek, M. / Baji, P. / Balogh, O. / V. Hevér, N. / Gulacsi, L. et al. | 2013
-
Burden of Infusion-Related Costs and Staff Time for Rheumatoid Arthritis in the Hospital SettingOgden, K. / Cifaldi, M. / Quock, T. / Ganguli, A. et al. | 2013
-
Resource Utilisation and Costs of Total Hip Arthroplasty in the United Kingdom: A Descriptive AnalysisRaluy, M. / Burge, R. / Lambrelli, D. / MacLachlan, S. / Wu, N. / Chen, S. Y. / Schoenfeld, M. et al. | 2013
-
A Model to Evaluate the Immunogenicity Costs of Tumour Necrosis Factor-Alpha Inhibitors in Patients with Rheumatoid ArthritisHeeg, B. / Majer, I. / Stephens, J. M. / Tarallo, M. et al. | 2013
-
Three TNF-A-Inhibitors for Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic ArthritisIvakhnenko, O. / Rebrova, O. / Avxentyeva, M. / Khachatryan, G. et al. | 2013
-
How University Hospital of Crete Succeeded in Decreasing Cytostatics’ Budget in 2012?Gkogkozotou, V. K. / Asithianakis, P. et al. | 2013
-
Direct Medical Costs of Treating Diabetes-Related Complications in ArgentinaElgart, J. / De la Llave, G. / Camillucci, C. / Vega-Hernandez, G. / Watkins, M. / Hammerby, E. / Nikolajsen, A. / Gagliardino, J. J. et al. | 2013
-
Translation and Validation of Hindi Version of Diabetes Quality of Life – Measure (DQOL-M) in Indian Type 2 Diabetes PatientsPawar, S. / Thakurdesai, P. et al. | 2013
-
Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in ArgentinaGarcia Marti, S. / Alcaraz, A. / Valanzasca, P. / Garay Ulises, U. / McMullen, M. / Rey Ares, L. / Peirano, I. / Bessone, F. / Fainboim, H. / Gadano, A. et al. | 2013
-
Economic Evaluation of Direct Acting Antiviral (DAA) Treatments for Hepatitis C Virus (HCV) Infection in Previously Treated Patients from the Peruvian Health Care System PerspectiveAriza, J. G. / Hinojosa, R. et al. | 2013
-
Evaluation of Associations Among Biomarkers, Correlates and Treatment Efficacy in Clinical Studies in Patients Diagnosed with Non-Psychotic Major Depressive Disorder: A Literature ReviewGreene, N. / Greene, M. et al. | 2013
-
A Cost–Effectiveness And Budget Impact Analysis of Different Biologic Treatments for Psoriasis in ColombiaAriza, J. G. / Nuñez, C. et al. | 2013
-
Comparative Efficacy of Blood Pressure Lowering Drugs in Primary Prevention for Elderly PatientsBrouwers, F. / Cohen, A. A. / Courteau, J. / Farand, P. / Cloutier, L. / Asghari, S. / Vanasse, A. et al. | 2013
-
Economic Burden of Coronary Heart Disease in the Patients Attending National Heart Center, Kathmandu, NepalDangi, A. / Lohani, S. P. et al. | 2013
-
Cost of Adults> 50 Years Community-Acquired Pneumonia in ArgentinaGiglio, N. D. / Micone, P. / Giorgi, M. A. / Cursio, D. / Ramirez, J. / Peyrani, P. / Cané, A. et al. | 2013
-
Efecto De La Determinación De La Concentración Capilar De ProteÃna C Reactiva En La Tasa De Prescripción De Antibióticos Para El Tratamiento De Infección De VÃas Respiratorias Altas (Análisis De Costo-Efectividad)Mendez, G. F. / Contreras, I. / Keymur-Landeros, E. / Mejia-Arangure, E. et al. | 2013
-
Comparing Costs Per Clinical Remission of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Patients with Rheumatoid Arthritis: A Brazilian Private PerspectiveBuschinelli, C. T. / Tsuchiya, C. T. / Maximo, M. F. / Tobaruella, F. S. / Gonçalves, T. M. et al. | 2013
-
Costos Asociados a Eventos Cardiovasculares En Pacientes Con Artritis Reumatoide Afiliados Al Régimen Subsidiado En ColombiaUrrego Novoa, J. R. / Prieto Martinez, V. / López, L. et al. | 2013
-
Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis in Institutional Market in EcuadorAlbuja, M. F. / Torres, F. G. / Mould, J. / Estévez, C. et al. | 2013
-
Estudio De Costo/Utilidad Del Tratamiento Habitual De La Artritis Reumatoidea Mas Etanercept Versus Tratamiento Habitual Más Otros Biológicos Del Mercado Chileno Y Versus Tratamiento Habitual Sin BiológicosBiagini, L. / Pezzani, M. / Rojas, R. / Hoffmeister, L. / Fuentes, R. et al. | 2013
-
Descripción De Una Cohorte De Pacientes Con Artritis Reumatoide Tratados Con Etanercept (Enbrel®) Dentro De Un Programa De Atención En Un Centro Especializado En ColombiaJauregui, E. / Sanchez, O. / Romero, M. / Mantilla, R. / Maldonado, M. C. / Gonzalez, A. / Dominguez, A. / Valero, Y. / Morales, C. / Trouchon, M. C. et al. | 2013
-
Análisis De Costo-Efectividad Dl Tratamiento Profiláctico Versus a Demanda En Adultos Jóvenes Con Hemofilia a Severa En ColombiaOrdoñez Molina, J. E. / Orozco Giraldo, J. J. et al. | 2013
-
Burden of Multiple Sclerosis and Unmet Needs in Brazil: Measurement of Fatigue Using Modified Fatigue Impact ScaleSilva, N. L. / Takemoto, M. / Damasceno, B. / Fragoso, Y. D. / Finkelsztejn, A. / Gomes, M. et al. | 2013
-
Osteotomia De Acortamiento Radial En La Enfermedad De Kienbock (Seguimiento De 5 Años)Vazquez Alonso, F. et al. | 2013
-
Análisis De Costo-Efectividad Para El Manejo Farmacológico De La Hemofilia a Severa En 5 Entidades De Aseguramiento En ColombiaBryon, A. / Leisewitz, T. / Salgar, L. / Rodriguez, F. et al. | 2013
-
Change of Burden of Disease in German Rheumatoid Arthritis Patients Since the Uptake of TNF-Inhibitors: A Literature Review of German Real Life DataWolff, M. / Kleine, H. / Wittig, B. / Mentrup, S. et al. | 2013
-
Comparison of Clinical Characteristics of Patients with Rheumatoid Arthritis Receiving Their First Biologic in Europe Union and the United StatesNarayanan, S. / Baskett, A. / Lu, Y. / Hutchings, R. et al. | 2013
-
Burden of Dose Escalation with Biologics in Rheumatoid Arthritis: A Review of Frequency and CostsMoots, R. / Mays, R. / Li, C. / Stephens, J. / Tarallo, M. et al. | 2013
-
Systematic Literature Review and Validity Evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in Patients with Multiple SclerosisMeyer-Moock, S. / Feng, Y. Y. / Dippel, F. W. / Kohlmann, T. et al. | 2013
-
The Review of Publications of Pharmacoeconomic Research in Russia During 2007-2012Yagudina, R. / Kulikov, A. / Mirkasimova, G. / Litvinenko, M. et al. | 2013
-
Feasibility of Use of Medical Transcription Data for Real World Evidence Generation in the United States: A Pilot Study of Patients with Systemic Lupus Erythematosus Initiated on BelimumabNarayanan, S. et al. | 2013
-
Does It Matter? Discounting and Its Role in Analysing the Cost-Effectiveness of Preventative InterventionsStarkie Camejo, H. J. / Van Kriekinge, G. / Li, X. et al. | 2013
-
Comparison of Markov and Discrete Event Simulation Modeling Techniques with Application to Cost Effectiveness AnalysesChrosny, W. / Stevenson, M. / Munzer, A. et al. | 2013
-
A Review of Methods Used in Health Economic Models of Chronic Myeloid Leukemia InterventionsMarsh, K. / Xu, P. / Orfanos, P. / Benedict, A. / Desai, K. / Griebsch, I. et al. | 2013
-
Patient Preferences on Treatments for Erectil Dysfunction Defined by Means of Different Attribute Groups: The Method of Administration Is the Most Valued Attribute and the Orodispersible Tablet Is the Most Preferred LevelGutiérrez, P. / Rebollo, P. / Mendivil, J. / Vera, V. / Cazorla, D. / RodrÃguez-Aguilella, A. / Osorio, G. et al. | 2013
-
Reliability and Validity of a Thai Version of Lam Employment Absence and Productivity Scale (LEAPS)Pumpaisalchai, W. / Ruengorn, C. / Karahong, K. / Jamroenkhajonsuk, P. / Pongdoung, T. / Udombhornprabha, A. et al. | 2013
-
Structural Validation of the Chronic Venous Insufficiency Quality of Life Questionnaire-14 (CIVIQ-14) : A Confirmatory Factor AnalysisLe Moine, J. G. / Katumba, K. R. / Launois, R. et al. | 2013
-
Lost in Translation: Translatability of Psychiatric Terms – The Example of the Mini–International Neuropsychiatric Interview (M.I.N.I.)Boudrot, A. / Sheehan, D. / Acquadro, C. et al. | 2013
-
Cross (-Walk) at Your Own Peril! Comparing and Contrasting Cea Results When Individual-Level Utilities Are Derived from External Mapping Algorithms Rather Than Actually Observed ResponsesPatton, T. / Manca, A. / Palmer, S. / Sculpher, M. J. et al. | 2013
-
Estimating the Social Distribution of Health in EnglandAsaria, M. / Griffin, S. / Cookson, R. / Koh, J. et al. | 2013
-
Evaluation of the Psoriasis Area and Severity Index (PASI) as Patient Relevant Outcome in the Benefit Assessment of Psoriasis TherapiesGutknecht, M. / Augustin, M. / Rustenbach, S. J. / Schäfer, I. et al. | 2013
-
Recommendations for the Successful Linguistic Validation of Clinical Outcome Assessments for Limited Patient PopulationsMoravec, H. / Chulis, C. / Sweeney, E. et al. | 2013
-
Mapping the Oxford Hip Score (OHS) to EQ-5D: A Test of Model PerformanceSungher, D. K. / Diamantopoulos, A. et al. | 2013
-
Assessing Measurement Equivalence of Different Forms of Administration of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) Using Rasch AnalysisTwiss, J. / McKenna, S. / Graham, J. E. / Swetz, K. M. / Sloan, J. / Gomberg-Maitland, M. et al. | 2013
-
Handling Variability in Time Endpoints in Multi-Centre Time and Motion (T&M) Studies: A Case Study of Erythropoiesis-Stimulating Agents for Anaemia Management in 13 Centres in ItalyKritikou, P. / De Cock, E. / Proskorovsky, I. / Payne, K. A. / Tomic, R. et al. | 2013
-
Estimating Chronic Disease PREVALENCE from Claims Data: Reducing Bias by Accounting for Diseased Individuals Who Do Not Generate ClaimsSignorovitch, J. / De, G. / Drabo, E. / Guerin, A. et al. | 2013
-
Evaluating Overall Survival in Oncology Trials with Subsequent Therapies: A Methodological Review and Application in Non-Small Cell Lung CancerJonsson, L. / Fleischer, F. / Bluhmki, E. / Griebsch, I. et al. | 2013
-
Parameter Importance Assessment in a Health Economic Evaluation Model for Heart FailureCagdas, B. u. et al. | 2013
-
Methodology for Establishing Internal and External Validity When Propensity Score Matching Is UsedEisenberg, D. / Wasser, T. / Placzek, H. / Luthra, R. et al. | 2013
-
An Approach for Quantification of Patient Advocacy Group Input in the HTA ProcessHicks, N. / Toumi, M. et al. | 2013
-
Health Care Resource Use and Direct Costs Associated with Fragile X Syndrome (FXS) in the United StatesVekeman, F. / Gauthier-Loiselle, M. / Faust, E. / Lefebvre, P. / Lahoz, R. / Duh, M. S. / Sacco, P. et al. | 2013
-
Quality of Life Outcomes in Multiple Sclerosis: A Review of the LiteratureRouse, M. / McKenna, S. / Twiss, J. / Graham, J. E. / Wilburn, J. et al. | 2013
-
Patient-Centered Outcomes in Upper Limb Spasticity: Results from a Large International Cohort Study (ULIS-2)Balcaitiene, J. / Kurth, H. / Fheodoroff, K. / Jacinto, J. / Turner-Stokes, L. et al. | 2013
-
Long-Term Prolonged-Release Fampridine Treatment and Health-Related Quality of Life Outcomes: Interim Results of the Enable StudyNagels, G. / Macdonell, R. / Soelberg Sorensen, P. / Pozzilli, C. / Laplaud, D. / de Jong, B. / Silva, A. M. / Nicholas, R. / Gaebler, J. A. / Sun, J. et al. | 2013
-
Disease Burden Among Patients with Multiple Sclerosis Not Receiving Disease Modifying Treatments in Europe and the United StatesNarayanan, S. / Khan, H. / Gabriele, S. / White, J. et al. | 2013
-
The Financial Impact of Increasing Home-Based High Dose Haemodialysis and Peritoneal DialysisLiu, F. X. / Treharne, C. / Culleton, B. / Lees, L. / Arici, M. et al. | 2013
-
Long-Term Costs and Survival Associated with Immunosuppressant Following Liver Transplantation: A Markov ModelBianic, F. / Ricci, J. F. / Damera, V. / Bhattacharyya, S. / Irish, W. et al. | 2013
-
Cost-Effectiveness of Mirabegron Compared with Tolterodine ER 4mg for the Treatment of Patients with Overactive Bladder in the United Kingdom: Results from a Trial-Based ModelAballéa, S. / Maman, K. / Desroziers, K. / Nazir, J. / Odeyemi, I. A. / Hakimi, Z. / Garnham, A. / Toumi, M. et al. | 2013
-
Value Judgments in Health Technology Assessment Process in BrazilSantoro Neto, L. / Ferraz, M. B. et al. | 2013
-
Perfil De Adesão Aos Planos De BenefÃcio Em MedicamentosSantana, C. F. / Ferreira, C. N. / Paloni, E. D. / Drago, S. / Salles, G. R. / Bonachela, F. / Souza, C. / Abreu, A. A. et al. | 2013
-
Single Use Devices in Argentina: Economic Evaluation of a “Reuse†Versus a “Single Use†PolicyGaray, O. U. / Garcia Elorrio, E. / Rodriguez, V. / Spira, C. / Augustovski, F. / Pichon Riviere, A. / GarcÃa MartÃ, S. et al. | 2013
-
Following the Western HTA Model in Latin America: A Self-Fulfilling Prophecy?Kirpekar, S. et al. | 2013
-
The Notification of Preliminary Investigation (NIP) of the Federal Regulatory Agency of Private Health and Insurance and Plans (ANS): A Tool to Facilitate the Access to the Mandatory CoverageSilva, F. H. et al. | 2013
-
The Burden of Caregiving in Cancer: The Status of Clinical ResearchFoster, R. E. / Bardos, J. I. / Wilson, T. J. / Hamerslag, L. / Kusel, J. et al. | 2013
-
Can the Use of Social Media and Mobile Apps Improve Patient Knowledge of Disease and Health Outcomes? A Systematic ReviewAbogunrin, S. / Martin, A. et al. | 2013
-
Budget Impact of HPV16/18 Genotyping Tests for the Management of Non-concordant Cotesting Cervical Cancer Screening Results: A United States Payer PerspectiveHuang, J. / Hertz, D. / Conner, A. / Garfield, S. et al. | 2013
-
Examining the Burden of Illness of the United States Veteran Patients Diagnosed with Alzheimer’s DiseaseWang, L. / Xie, L. / Du, J. / Li, L. / Baser, O. et al. | 2013
-
Medication Adherence and Adverse Health Outcomes in Community Dwelling Older PatientsCahir, C. / Fahey, T. / Teljeur, C. / Bennett, K. et al. | 2013
-
Comparison of Elderly Adults by Number of Rx Medications Used: Results from the National Health and Wellness Survey Across 5EU CountriesAnnunziata, K. / Isherwood, G. / Sternbach, N. et al. | 2013
-
Potentially Inappropriate Prescribing (PIP) and Its Association with Instrumental Activities of Daily Living (IADL) Impairment in Older PeopleMoriarty, F. / Cahir, C. / Fahey, T. / Bennett, K. et al. | 2013
-
Patient Survey Data Results: Preferences for Reminders in Pro StudiesRoss, E. / Ross, J. / Holzbaur, E. et al. | 2013
-
Do EMA and FDA Have Different Opinions/Requirements in Terms of Pediatric Studies for Sitagliptin (Alone or in Combination)?Caron, M. / Emery, M. P. / Maier, W. et al. | 2013
-
Effect of Antiviral Treatment Rates on the Predicted Future Burden of Genotype-1 Chronic Hepatitis C in the United KingdomWesterhout, K. Y. / Treur, M. / Cerri, K. et al. | 2013
-
Comparative Effectiveness of Triple Therapy Versus Dual Therapy for Chronic Hepatitis C Virus Infection in KazakhstanAlmadiyeva, A. / Kostyuk, A. / Nurgozhin, T. et al. | 2013
-
Comparison of the Health Care Costs and Utilizations Between Patients Diagnosed with the Hepatitis B Virus Versus Those WithoutXie, L. / Wang, L. / Kariburyo, M. F. / Li, L. / Wang, Y. / Baser, O. et al. | 2013
-
Cost-Effectiveness of Universal Vaccination Against Varicella in the Netherlandsde Boer, P. T. / Postma, M. J. et al. | 2013
-
Health Economics Assessment of Rilpivirine Versus Comparators as First-Line Antiretroviral Therapies in HIV-1 Patients with a Viral Load (VL) ≤100,000 Copies/mL in FranceCognet, M. / Druais, S. / Lahoulou, R. / Havet, D. / Guillon, P. et al. | 2013
-
Costs Associated with Cold Chain Used to Store and Transport Thermally Unstable Antiretroviral DrugsOmelyanovsky, V. / Fedyaeva, V. K. et al. | 2013
-
A Case Study of FDA Practices and Its Influence on Regulatory and Reimbursement Decisions for DarunavirRubinstein, J. / Rubinstein, E. / Jaksa, A. / Jao, R. / Satyarthi, H. / Liden, D. et al. | 2013
-
Characteristics of Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Inhaled Corticosteroid/Long-Acting b2-ß2-agonist (ICS/LABA) Fixed Combination Products in English Primary CareBlak, B. T. / Rigney, U. / Emmas, C. / Hamblin, A. et al. | 2013
-
The Efficiency of Preoperative Physiotherapy in Patients with Chronic Obstructive Pulmonary Disease Undergoing Open Heart SurgerySió, E. / Bajsz, V. / Mazur, M. / Molics, B. / Boncz, I. / Gombos, G. et al. | 2013
-
Assessing Non-Inferiority of Aclidinium Bromide 400 mG Bid Versus Tiotropium 18 mG and 5 mG Qd in Patients with Chronic Obstructive Pulmonary Disease (COPD) by Means of a Network Meta-AnalysisKarabis, A. / Lindner, L. / Prior, M. et al. | 2013